<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1" specific-use="sps-1.7" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Arq Bras Cardiol</journal-id>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">y84qpJtytPbsWHc7QKthgPd</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2018000400354</article-id>
      <article-id pub-id-type="doi">10.5935/abc.20180062</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Applicability of Longitudinal Strain of Left Ventricle in Unstable Angina</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Santos</surname>
            <given-names>Natasha Soares Sim&#245;es dos</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
          <xref ref-type="corresp" rid="c1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Vilela</surname>
            <given-names>Andrea de Andrade</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Barretto</surname>
            <given-names>Rodrigo Bellio de Mattos</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Vale</surname>
            <given-names>Marcela Paganelli do</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rezende</surname>
            <given-names>Mariana Oliveira</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ferreira</surname>
            <given-names>Murilo Castro</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Andrade</surname>
            <given-names>Alexandre Jos&#233; Aguiar</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Scorsioni</surname>
            <given-names>Nelson Henrique Goes</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Queiroga</surname>
            <given-names>Ol&#237;via Ximenes de</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bihan</surname>
            <given-names>David Le</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <aff id="aff1">
          <institution content-type="orgname">Instituto Dante Pazzanese de Cardiologia</institution>
          <addr-line>
            <city>S&#227;o Paulo</city>
            <state>SP</state>
          </addr-line>
          <country country="BR">Brazil</country>
          <institution content-type="original">Instituto Dante Pazzanese de Cardiologia, S&#227;o Paulo, SP - Brazil</institution>
          <institution content-type="normalized">Instituto Dante Pazzanese de Cardiologia</institution>
        </aff>
      </contrib-group>
      <author-notes>
        <corresp id="c1"><bold>Mailing Address: Natasha Soares Sim&#245;es dos Santos,</bold> Av. Dante Pazzanese, 500. Postal Code 04012-909, Vila Mariana, S&#227;o Paulo, SP - Brazil. E-mail: <email>natashasimoes@hotmail.com</email>, <email>mariananatasha@yahoo.com.br</email>
				</corresp>
        <fn fn-type="con">
          <p>
            <bold>Author contributions</bold>
          </p>
          <p>Conception and design of the research: Santos NSS, Vilela AA, Barretto RBM, Rezende MO, Ferreira MC, Andrade AJA, Scorsioni NHG, Queiroga OX, Le Bihan D; Acquisition of data: Santos NSS, Vilela AA, Vale MP, Rezende MO, Ferreira MC, Andrade AJA, Scorsioni NHG, Queiroga OX; Analysis and interpretation of the data: Santos NSS, Vilela AA, Barretto RBM, Vale MP, Rezende MO, Ferreira MC, Andrade AJA, Scorsioni NHG, Queiroga OX, Le Bihan D; Statistical analysis and Critical revision of the manuscript for intellectual content: Santos NSS, Vilela AA, Rezende MO, Ferreira MC, Andrade AJA, Scorsioni NHG, Queiroga OX; Obtaining financing and Writing of the manuscript: Vilela AA.</p>
        </fn>
        <fn fn-type="conflict">
          <p>
            <bold>Potential Conflict of Interest</bold>
          </p>
          <p>No potential conflict of interest relevant to this article was reported.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <month>04</month>
        <year>2018</year>
      </pub-date>
      <volume>110</volume>
      <issue>4</issue>
      <fpage>354</fpage>
      <lpage>361</lpage>
      <history>
        <date date-type="received">
          <day>31</day>
          <month>01</month>
          <year>2017</year>
        </date>
        <date date-type="rev-recd">
          <day>13</day>
          <month>11</month>
          <year>2017</year>
        </date>
        <date date-type="accepted">
          <day>22</day>
          <month>11</month>
          <year>2017</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/" xml:lang="en">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited</license-p>
        </license>
      </permissions>
      <abstract>
        <title>Abstract</title>
        <sec>
          <title>Background:</title>
          <p>Unstable angina (UA) is a common cause of hospital admission; risk stratification helps determine strategies for treatment.</p>
        </sec>
        <sec>
          <title>Objective:</title>
          <p>To determine the applicability of two-dimensional longitudinal strain (SL2D) for the identification of myocardial ischemia in patients with UA.</p>
        </sec>
        <sec>
          <title>Methods:</title>
          <p>Cross-sectional, descriptive, observational study lasting 60 days. The sample consisted of 78 patients, of which fifteen (19.2%) were eligible for longitudinal strain analysis. The value of p &lt; 0.05 was considered significant.</p>
        </sec>
        <sec>
          <title>Results:</title>
          <p>The group of ineligible patients presented: a lower proportion of women, a higher prevalence of diabetes mellitus (DM), use of ASA, statins and beta-blockers and larger cavity diameters. The main causes of non-applicability were: presence of previous infarction (56.4%), previous CTA (22.1%), previous MRI (11.5%) or both (16.7%) and the presence of specific electrocardiographic abnormalities (12.8%). SL2D assessment revealed a lower global strain value in those with stenosis greater than 70% in some epicardial coronary arteries (17.1 [3.1] versus 20.2 [6.7], with p = 0.014). Segmental strain assessment showed an association between severe CX and RD lesions with longitudinal strain reduction of lateral and inferior walls basal segments; (14 [5] versus 21 [10], with p = 0.04) and (12.5 [6] versus 19 [8], respectively).</p>
        </sec>
        <sec>
          <title>Conclusion:</title>
          <p>There was very low SL2D applicability to assess ischemia in the studied population. However, the global strain showed a correlation with the presence of significant coronary lesion, which could be included in the UA diagnostic arsenal in the future.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords:</title>
        <kwd>Angina, unstable / physiopathology</kwd>
        <kwd>Ventricular Dysfunction, Left</kwd>
        <kwd>Myocardial Ischemia / physiopathology</kwd>
        <kwd>Strain</kwd>
        <kwd>Echocardiography / methods</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>In United States, unstable angina (UA) is the most common cardiovascular cause of hospitalization and is responsible for most hospitalizations in coronary units.<xref ref-type="bibr" rid="B1">1</xref> The diagnosis of UA is performed by clinical criteria based on angina duration and intensity.<xref ref-type="bibr" rid="B2">2</xref> UA patient has a variable prognosis for unfavorable events such as acute myocardial infarction (AMI), recurrence of angina, necrosis biomarkers, ventricular function and need for myocardial revascularization.<xref ref-type="bibr" rid="B3">3</xref>
			</p>
      <p>Speckle tracking (ST) is a technology introduced in the 1980s that allows the quantification of global and regional myocardial deformity by tracking the natural heart muscle "acoustic marks" by ultrasound, presenting reduced values in presence of myocardial ischemia.<xref ref-type="bibr" rid="B4">4</xref><sup>,</sup><xref ref-type="bibr" rid="B5">5</xref> ST allows myocardial strain calculation and has shown great utility in the identification of subendocardial ischemia as in unstable angina, with greater sensitivity and specificity than two-dimensional echocardiogram.<xref ref-type="bibr" rid="B6">6</xref>
			</p>
      <p>However, for ST to track adequately speckles, there are some variables that may interfere in deformity analysis, so when present, they may give erroneous results or even impede myocardial strain analysis. In addition, for myocardial ischemia identification in UA patients, infarction previous myocardial presence or other myocardial injury (such as significant valvar heart disease) may alter myocardial deformity and cause an incorrect analysis of deformity decrease true cause. These are the variables that interfere in myocardial deformity correct analysis, and for that reason, they are considered exclusion criteria in the majority of published studies (aimed at analyzing acute ischemia): previous infarction, atrial fibrillation, left bundle branch block, ventricular arrhythmia aortic and/or mitral valvar disease, previous cardiac surgery, ventricular hypertrophy, cardiac pacemaker and inadequate acoustic window.<xref ref-type="bibr" rid="B7">7</xref>
			</p>
      <p>The main objective is to study the applicability prevalence of two-dimensional longitudinal strain (SL2D) in all hospitalized patients diagnosed with UA during the 60-day observation period.</p>
      <p>The secondary objective is to evaluate the diagnostic capacity of SL2D in the identification of culprit vessel due to ischemic event in UA patients.</p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <p>This is a cross-sectional, descriptive, performed at the Emergency Room (ER) and Coronary Unit (CU) of Dante Pazzanese Institute of Cardiology (IDPC).</p>
      <p>Inclusion criteria were: hospitalized patients of both sexes, age greater than 18 years and clinical diagnosis of UA who were admitted to IDPC service during the study period and who accepted the participation in the study, having signed informed consent form. We emphasize that there was no calculation of sample size. A census was carried out of all patients who had inclusion criteria. Patient arrival to IDPC service was by convenience.</p>
      <p>Exclusion criterion was the change in diagnosis during hospitalization. These cases occurred in patients who entered the service with initial chest pain and after propaedeutic and complementary exams, diagnosis of UA was ruled out. In case of differential diagnosis and closing as final diagnosis: acute myocardial infarction (AMI) with supra or no supra-ST segment, aortic dissection, pulmonary embolism and aortic stenosis.</p>
      <p>We analyzed clinical-epidemiological and electrocardiographic characteristics, as well as tests collection for troponin I and creatinine.</p>
      <p>Risk stratification was done using GRACE risk score.<xref ref-type="bibr" rid="B8">8</xref><sup>.</sup><xref ref-type="bibr" rid="B9">9</xref>
			</p>
      <p>Electrocardiographic analysis was performed by two experienced cardiologists; in case of disagreement regarding the diagnosis, tracing would be analyzed by a specialized service in the electrocardiographic reports of the institution where the research was carried out. Transthoracic echocardiography was performed within 48 hours of patient precordial pain last episode in ER or CU. The equipment for conducting examination was GE&#174; Vivid E9 (General Electric Medical System, Norway) with transducer "array in phase" with 3.5 megahertz emission frequency. Images obtained during the examination were acquired with harmonic, in a repetition of frames between 50 and 70 frames/second, in digital clips form ( three consecutive cycles average) and recorded in CDs for later analysis in workstation EchoPAC PC version 6.0.1&#174; (GE VingmedUltrasound).</p>
      <p>According to American Society of Echocardiography and European Society of Echocardiography committee guidelines, which standardized the acquisition of tomographic sections obtained during echocardiographic examinations, with the patient in left lateral decubitus and electrocardiogram monitored, we acquired transthoracicly echocardiographic images by the Spectral Doppler (pulsatile and continuous) Doppler and flow mapping in color.<xref ref-type="bibr" rid="B10">10</xref>
			</p>
      <p>Measures acquired:</p>
      <p>
        <list list-type="bullet">
          <list-item>
            <p>Two-dimensional: diastolic and systolic left ventricular (LV) diameter, left atrium anteroposterior diameter (LA), aortic root diameter, interventricular septum and posterior wall thickness. LV diastolic and systolic volume. Calculation of LV ejection fraction (EF) by the modified biplanar Simpson method.</p>
          </list-item>
          <list-item>
            <p>Doppler and Color Flow Mapping: Mitral flow with spectral Doppler (pulsatile and continuous) for diastolic function analysis and mitral valvopathy quantification, when present. Aortic flow with spectral Doppler (pulsatile and continuous), to determine aortic valve opening and closing (to mark the systolic event), and aortic valvopathy quantification, when present. Valve lesions diagnosis and quantification followed American Society of Echocardiography recommendations.<xref ref-type="bibr" rid="B11">11</xref>
						</p>
          </list-item>
        </list>
      </p>
      <p>The technique to obtain longitudinal tension was done as follows:</p>
      <p>
        <list list-type="bullet">
          <list-item>
            <p>Marking systolic event with aortic flow pulsating Doppler.</p>
          </list-item>
          <list-item>
            <p>Determination of three points of endocardial border in each of the following images: apical 3 chambers (at anterosseptal wall base, at inferolateral wall base and at apex), apical 4 chambers (at septum base, at lateral wall base and at apex) and apical 2 chambers (at inferior wall base, at anterior wall base and at apex).</p>
          </list-item>
          <list-item>
            <p>Through the Automatic Function Imaging&#174; (AFI) tool, the deformation of each of the 17 myocardial segments was automatically calculated, providing posteriorly left ventricle global deformation (analyzed segments mean). The program provides SL2D curves and polar map with longitudinal strain values in each segment.</p>
          </list-item>
        </list>
      </p>
      <p>The maximum absolute value of the two-dimensional strain curve was defined as the systolic peak. Adjacent myocardial segments with altered strain value were defined as ischemic territory, correlating them with coronary irrigation, according to polar map shown in <xref ref-type="fig" rid="f1">Figure 1</xref>.</p>
      <p>
        <fig id="f1">
          <label>Figure 1</label>
          <caption>
            <title>Polar map with coronary irrigation correlation. AD: anterior descending coronary artery; CX: circumflex coronary artery; RD: right coronary artery.</title>
          </caption>
          <graphic xlink:href="1678-4170-abc-110-04-0354-80062-gf01.jpg"/></fig>
      </p>
      <p>According to the literature,<xref ref-type="bibr" rid="B7">7</xref><sup>,</sup><xref ref-type="bibr" rid="B12">12</xref><sup>,</sup><xref ref-type="bibr" rid="B13">13</xref> the situations mentioned below may lead to a change in myocardial deformity, or to a real deformity impairment, or by limitation of the software to identify acoustic marks during the cardiac cycle:</p>
      <p>
        <list list-type="bullet">
          <list-item>
            <p>Concentric ventricular hypertrophy (LVH);</p>
          </list-item>
          <list-item>
            <p>Aortic and/or mitral valvar diseases greater than moderate degree;</p>
          </list-item>
          <list-item>
            <p>Pacemaker pace;</p>
          </list-item>
          <list-item>
            <p>At least one of the following electrocardiographic changes: left bundle branch block (LBBB), atrial fibrillation (AF) rhythm and complex ventricular arrhythmia;</p>
          </list-item>
          <list-item>
            <p>Secondary unstable angina (acute anemia, tachyarrhythmia and infection);</p>
          </list-item>
          <list-item>
            <p>Prior AMI or prior myocardial (percutaneous or surgical) revascularization procedure and</p>
          </list-item>
          <list-item>
            <p>Inadequate acoustic window.</p>
          </list-item>
        </list>
      </p>
      <p>Based on the above, we hypothesized that the presence of one of these alterations may impair SL2D analysis in severe coronary disease identification in UA patients. These concepts has fundamental importance for the knowledge of SL2D real applicability in this population, when the examination purpose is to evaluate coronary disease responsible for the acute condition.</p>
      <p>Patients eligible for bidimensional echocardiogram with longitudinal strain were submitted to the method by two skilled and experienced professionals, who did not have access to information on patient coronary anatomy evaluated until the conclusion of the study.</p>
      <p>Results of cardiac catheterization (CC) and Coronary Angiography by Computed Tomography (CACT) exams were also analyzed. Stenosis greater than or equal to 70% in epicardial coronary arteries or stenosis greater than or equal to 50% in left main coronary artery (LMCA) was considered.</p>
      <p>The sample was divided into two groups: Group A - patients in whom it was possible to analyze by SL2D and Group B - patients in whom analysis by SL2D was not possible.</p>
      <p>The research protocol was submitted and approved by the institution's Ethics and Research Committee.</p>
      <p>There was no interference in individual medical conduct due to participation in the study. Such conduct was based on ER and CU routine that corresponds to US and national guidelines<xref ref-type="bibr" rid="B3">3</xref><sup>,</sup><xref ref-type="bibr" rid="B14">14</xref> for UA patients treatment patients.</p>
      <sec>
        <title>Statistical analysis</title>
        <p>Statistical analysis was performed with Statistical Package for Social Sciences (SPSS), version 19.0.</p>
        <p>Kolmogorov-Smirnov and Shapiro-Wilk tests were performed to verify our sample normal distribution. As the normality hypothesis was rejected, we used nonparametric tests for analysis.</p>
        <p>Groups were compared using Mann-Whitney test and Fisher exact test as appropriate.</p>
        <p>Continuous variables were presented as median and interquartile range, and categorical variables were expressed as percentage (%).</p>
        <p>ROC curve was used to evaluate SL2D discriminative power in severe coronary stenosis identification (&#8805; 70%) in UA patients.</p>
        <p>Level of significance was 5%.</p>
      </sec>
    </sec>
    <sec sec-type="results">
      <title>Results</title>
      <p>We evaluated 93 patients diagnosed with UA at admission to ER; however, fifteen (16.2%) patients were excluded from the study due to diagnosis change during hospitalization, 13 (14%) cases with non-ST-segment AMI, one (1.1%) with UA post-MI and one (1.1%) with type A aortic dissection.</p>
      <p>At the end, 78 UA patients were investigated, of which fifteen (19.2%) were eligible for longitudinal strain analysis.</p>
      <p>Main population clinical characteristics are summarized in <xref ref-type="table" rid="t1">Table 1</xref>.</p>
      <table-wrap id="t1">
        <label>Table 1</label>
        <caption>
          <title>Clinical characteristics of studied population (n = 78)</title>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup>
            <col width="50%"/>
            <col width="50%"/>
          </colgroup>
          <thead>
            <tr>
              <th align="left">
							</th>
              <th align="center">Median [p25- 75]</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left">Age (years)</td>
              <td align="center">61,5 [53 - 69]</td>
            </tr>
            <tr>
              <td align="left">
                <bold>Gender (%)</bold>
              </td>
              <td align="center">
							</td>
            </tr>
            <tr>
              <td align="left">Male</td>
              <td align="center">60,3%</td>
            </tr>
            <tr>
              <td align="left">Female</td>
              <td align="center">39,4%</td>
            </tr>
            <tr>
              <td align="left">BMI (Kg/m<sup>2</sup>)</td>
              <td align="center">28,16 [24,47 - 30,71]</td>
            </tr>
            <tr>
              <td align="left">SBP (mmHg)</td>
              <td align="center">137 [122,75 - 154,25]</td>
            </tr>
            <tr>
              <td align="left">HR (bpm)</td>
              <td align="center">74 [69 - 83,5]</td>
            </tr>
            <tr>
              <td align="left">Serum Creatinine (mg/dL)</td>
              <td align="center">0,9 [0,7 - 1,1]</td>
            </tr>
            <tr>
              <td align="left">GRACE (points)</td>
              <td align="center">95 [81 - 117]</td>
            </tr>
            <tr>
              <td align="left">Troponin (pg/mL)</td>
              <td align="center">0,02 [0,01 - 0,05]</td>
            </tr>
            <tr>
              <td align="left">High blood pressure (%)</td>
              <td align="center">88,5%</td>
            </tr>
            <tr>
              <td align="left">Diabetes (%)</td>
              <td align="center">38,5%</td>
            </tr>
            <tr>
              <td align="left">Smoking (%)</td>
              <td align="center">32,1%</td>
            </tr>
            <tr>
              <td align="left">Dyslipidemia (%)</td>
              <td align="center">65,4%</td>
            </tr>
            <tr>
              <td align="left">Family history for CAD (%)</td>
              <td align="center">19,2%</td>
            </tr>
            <tr>
              <td align="left">Known CAD (%)</td>
              <td align="center">66,7%</td>
            </tr>
            <tr>
              <td align="left">
                <bold>Medications in use (%)</bold>
              </td>
              <td align="center">
							</td>
            </tr>
            <tr>
              <td align="left">ACEI</td>
              <td align="center">32,1%</td>
            </tr>
            <tr>
              <td align="left">ARB</td>
              <td align="center">41%</td>
            </tr>
            <tr>
              <td align="left">Beta blocker</td>
              <td align="center">65,4%</td>
            </tr>
            <tr>
              <td align="left">Acetylsalicylic acid</td>
              <td align="center">82,1%</td>
            </tr>
            <tr>
              <td align="left">Other antiplatelet</td>
              <td align="center">29,5%</td>
            </tr>
            <tr>
              <td align="left">Calcium channel blocker</td>
              <td align="center">33,3%</td>
            </tr>
            <tr>
              <td align="left">Statin</td>
              <td align="center">76,9%</td>
            </tr>
            <tr>
              <td align="left">Nitrate</td>
              <td align="center">37,2%</td>
            </tr>
            <tr>
              <td align="left">
                <bold>Prior Intervention (%)</bold>
              </td>
              <td align="center">
							</td>
            </tr>
            <tr>
              <td align="left">Surgical revascularization</td>
              <td align="center">11,5%</td>
            </tr>
            <tr>
              <td align="left">Angioplasty</td>
              <td align="center">22,1%</td>
            </tr>
            <tr>
              <td align="left">Angioplasty + Surgical revascularization</td>
              <td align="center">16,7%</td>
            </tr>
            <tr>
              <td align="left">Previous MI (%)</td>
              <td align="center">56,4%</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="TFN1">
            <p>BMI: body mass index; SBP: systolic blood pressure; HR: heart rate; CAD: coronary artery disease; AMI: acute myocardial infarction; ACEI: angiotensinogen converting enzyme inhibitor; ARB: angiotensin receptor AT-2 blocker.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>About 70% of sample had no change in QRS complex duration or morphology complex; more than half (60.3%) showed no change in ventricular repolarization. Five patients (6.4%) presented ST segment depression on admission. Main electrocardiographic changes are detailed in <xref ref-type="table" rid="t2">Table 2</xref>.</p>
      <table-wrap id="t2">
        <label>Table 2</label>
        <caption>
          <title>Electrocardiographic findings (n = 78)</title>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup>
            <col width="50%"/>
            <col width="50%"/>
          </colgroup>
          <thead>
            <tr>
              <th align="left">Change</th>
              <th align="center">Frequency (%)</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left">LBBCD</td>
              <td align="center">10,3%</td>
            </tr>
            <tr>
              <td align="left">RBBB</td>
              <td align="center">3,8%</td>
            </tr>
            <tr>
              <td align="left">LASDB</td>
              <td align="center">2,6%</td>
            </tr>
            <tr>
              <td align="left">RBBB + LASDB</td>
              <td align="center">2,6%</td>
            </tr>
            <tr>
              <td align="left">LBBB</td>
              <td align="center">3,8%</td>
            </tr>
            <tr>
              <td align="left">Q wave pathological</td>
              <td align="center">3,8%</td>
            </tr>
            <tr>
              <td align="left">Pacemaker pace</td>
              <td align="center">3,8%</td>
            </tr>
            <tr>
              <td align="left">High response AF</td>
              <td align="center">1,3%</td>
            </tr>
            <tr>
              <td align="left">CVR anterosseptal</td>
              <td align="center">5,1%</td>
            </tr>
            <tr>
              <td align="left">Previous CVR</td>
              <td align="center">5,1%</td>
            </tr>
            <tr>
              <td align="left">Lower CVR</td>
              <td align="center">9%</td>
            </tr>
            <tr>
              <td align="left">Side CVR</td>
              <td align="center">7,7%</td>
            </tr>
            <tr>
              <td align="left">Diffuse CVR</td>
              <td align="center">11,5%</td>
            </tr>
            <tr>
              <td align="left">Infra/ST &gt; 0,5 mm</td>
              <td align="center">1,3%</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="TFN2">
            <p>LBBCD: left bundle branch conduction disorder; RBBB: right bundle branch block; LASDB: left anterior superior divisional block; CVR: change in ventricular repolarization; LBBB: left bundle branch block; AF: atrial fibrillation.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>Of the 63 patients in whom the longitudinal strain was not applied, 40 (63.5%) performed two-dimensional echocardiography during ER stay. Main echocardiographic findings of this population, including the 15 patients submitted to SL2D, are shown in <xref ref-type="table" rid="t3">Table 3</xref>.</p>
      <table-wrap id="t3">
        <label>Table 3</label>
        <caption>
          <title>Echocardiographic findings (n = 55)</title>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup>
            <col width="50%"/>
            <col width="50%"/>
          </colgroup>
          <thead>
            <tr>
              <th align="left">Variable</th>
              <th align="center">Median [p25 - p75]</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left">LVEF Simpson</td>
              <td align="center">0,59 [0,5 - 0,65]</td>
            </tr>
            <tr>
              <td align="left">LA (mm)</td>
              <td align="center">39 [36 - 42]</td>
            </tr>
            <tr>
              <td align="left">LVFDD (mm)</td>
              <td align="center">51 [48 - 56]</td>
            </tr>
            <tr>
              <td align="left">LVFSD (mm)</td>
              <td align="center">32 [30 - 37,75]</td>
            </tr>
            <tr>
              <td align="left">Septum (mm)</td>
              <td align="center">10 [9 - 11]</td>
            </tr>
            <tr>
              <td align="left">Posterior wall (mm)</td>
              <td align="center">9 [9 - 11]</td>
            </tr>
            <tr>
              <td align="left">Mass index (g/m<sup>2</sup>)</td>
              <td align="center">124,5 [110 - 153,5]</td>
            </tr>
            <tr>
              <td align="left">PASP (mmHg)</td>
              <td align="center">32 [31 - 36]</td>
            </tr>
            <tr>
              <td align="left">Aorta root (mm)</td>
              <td align="center">34 [31 - 36]</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="TFN3">
            <p>LVEF: left ventricular ejection fraction; LA: measurement of the left atrium; LVFDD: left ventricle final diastolic diameter; LVFSD: left ventricular final systolic diameter; PASP: pulmonary artery systolic pressure.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>In total, 50 patients completed the investigation with CC and five with CACT. In the first exam, three patients presented LMCA severe lesions (3.9%), 22 (28.2%) anterior descending coronary artery lesions (AD), 21 (26.9%) in right coronary artery, 2%) in circumflex coronary artery (CX). In patients submitted to CACT, one presented AD severe damage (1.3%) and one in RD (1.3%).</p>
      <p>During hospitalization, 23 patients (29.5%) were submitted to intervention. Coronary transluminal angioplasty (CTA) was the main revascularization therapy. In three cases (3.8%), revascularization was surgical.</p>
      <p>Comparing patients eligible for longitudinal strain analysis (group A) to those not eligible (group B), we found that group B had a lower proportion of women, a higher prevalence of diabetes, left cavities larger dimensions, larger root aorta diameter and lower systolic function on two-dimensional echocardiography; in addition to a higher ASA use rate, statins and beta-blockers, according to the data in <xref ref-type="table" rid="t4">Table 4</xref>.</p>
      <table-wrap id="t4">
        <label>Table 4</label>
        <caption>
          <title>Clinical and echocardiographic characteristics of patients undergoing longitudinal strain analysis (group A, n = 15) compared to non-submitted patients (group B, n = 63)</title>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup>
            <col width="16%"/>
            <col width="16%"/>
            <col width="16%"/>
            <col width="16%"/>
            <col width="16%"/>
            <col width="16%"/>
          </colgroup>
          <thead>
            <tr>
              <th align="left" rowspan="2">
							</th>
              <th align="center" colspan="2" style="border-bottom-width:thin;border-bottom-style:solid">Group A</th>
              <th align="center" colspan="2" style="border-bottom-width:thin;border-bottom-style:solid">Group B</th>
              <th align="center" rowspan="2">p</th>
            </tr>
            <tr>
              <th align="center">Median</th>
              <th align="center">Interquartile Interval</th>
              <th align="center">Median</th>
              <th align="center">Interquartile Interval</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left">Age (years)</td>
              <td align="center">57</td>
              <td align="center">16</td>
              <td align="center">62</td>
              <td align="center">16</td>
              <td align="center">0,899</td>
            </tr>
            <tr>
              <td align="left">
                <bold>Gender (%)</bold>
              </td>
              <td align="center">
							</td>
              <td align="center">
							</td>
              <td align="center">
							</td>
              <td align="center">
							</td>
              <td align="center">
							</td>
            </tr>
            <tr>
              <td align="left">Male</td>
              <td align="center">33,3%</td>
              <td align="center">
							</td>
              <td align="center">66,7%</td>
              <td align="center">
							</td>
              <td align="center" rowspan="2">0,037</td>
            </tr>
            <tr>
              <td align="left">Female</td>
              <td align="center">66,7%</td>
              <td align="center">
							</td>
              <td align="center">33,3%</td>
              <td align="center">
							</td>
            </tr>
            <tr>
              <td align="left">BMI (Kg/m<sup>2</sup>)</td>
              <td align="center">28,62</td>
              <td align="center">7,2</td>
              <td align="center">28,12</td>
              <td align="center">6,56</td>
              <td align="center">0,903</td>
            </tr>
            <tr>
              <td align="left">SBP (mmHg)</td>
              <td align="center">143</td>
              <td align="center">33</td>
              <td align="center">137</td>
              <td align="center">31</td>
              <td align="center">0,510</td>
            </tr>
            <tr>
              <td align="left">HR (bpm)</td>
              <td align="center">78</td>
              <td align="center">23</td>
              <td align="center">74</td>
              <td align="center">14</td>
              <td align="center">0,824</td>
            </tr>
            <tr>
              <td align="left">Creatinine (mg/dL)</td>
              <td align="center">0,7</td>
              <td align="center">0,5</td>
              <td align="center">0,9</td>
              <td align="center">0,3</td>
              <td align="center">0,127</td>
            </tr>
            <tr>
              <td align="left">GRACE (points)</td>
              <td align="center">94</td>
              <td align="center">27</td>
              <td align="center">97</td>
              <td align="center">36</td>
              <td align="center">0,287</td>
            </tr>
            <tr>
              <td align="left">Hypertension (%)</td>
              <td align="center">80%</td>
              <td align="center">
							</td>
              <td align="center">90,5%</td>
              <td align="center">
							</td>
              <td align="center">0,363</td>
            </tr>
            <tr>
              <td align="left">Diabetes (%)</td>
              <td align="center">13,3%</td>
              <td align="center">
							</td>
              <td align="center">44,4%</td>
              <td align="center">
							</td>
              <td align="center">0,037</td>
            </tr>
            <tr>
              <td align="left">Smoking (%)</td>
              <td align="center">33,3%</td>
              <td align="center">
							</td>
              <td align="center">31,7%</td>
              <td align="center">
							</td>
              <td align="center">1</td>
            </tr>
            <tr>
              <td align="left">Dyslipidemia (%)</td>
              <td align="center">60%</td>
              <td align="center">
							</td>
              <td align="center">66,7%</td>
              <td align="center">
							</td>
              <td align="center">0,764</td>
            </tr>
            <tr>
              <td align="left">Family history for CAD (%)</td>
              <td align="center">26,7%</td>
              <td align="center">
							</td>
              <td align="center">17,5%</td>
              <td align="center">
							</td>
              <td align="center">0,470</td>
            </tr>
            <tr>
              <td align="left">LVEF Simpson</td>
              <td align="center">0,65</td>
              <td align="center">0,08</td>
              <td align="center">0,55</td>
              <td align="center">0,18</td>
              <td align="center">0,006</td>
            </tr>
            <tr>
              <td align="left">LA (mm)</td>
              <td align="center">37</td>
              <td align="center">5</td>
              <td align="center">40</td>
              <td align="center">9</td>
              <td align="center">0,009</td>
            </tr>
            <tr>
              <td align="left">LVFDD (mm)</td>
              <td align="center">48</td>
              <td align="center">5</td>
              <td align="center">53,5</td>
              <td align="center">9</td>
              <td align="center">0,007</td>
            </tr>
            <tr>
              <td align="left">LVFSD (mm)</td>
              <td align="center">31</td>
              <td align="center">6</td>
              <td align="center">37</td>
              <td align="center">7</td>
              <td align="center">0,112</td>
            </tr>
            <tr>
              <td align="left">Septum (mm)</td>
              <td align="center">10</td>
              <td align="center">2</td>
              <td align="center">10</td>
              <td align="center">3</td>
              <td align="center">0,668</td>
            </tr>
            <tr>
              <td align="left">Posterior wall (mm)</td>
              <td align="center">9</td>
              <td align="center">1</td>
              <td align="center">10</td>
              <td align="center">2</td>
              <td align="center">0,118</td>
            </tr>
            <tr>
              <td align="left">Mass index (g/m<sup>2</sup>)</td>
              <td align="center">109</td>
              <td align="center">49</td>
              <td align="center">133,5</td>
              <td align="center">26</td>
              <td align="center">0,095</td>
            </tr>
            <tr>
              <td align="left">PASP (mmHg)</td>
              <td align="center">34</td>
              <td align="center">13</td>
              <td align="center">29,5</td>
              <td align="center">10</td>
              <td align="center">0,895</td>
            </tr>
            <tr>
              <td align="left">Aorta root (mm)</td>
              <td align="center">31</td>
              <td align="center">4</td>
              <td align="center">35</td>
              <td align="center">4</td>
              <td align="center">0,006</td>
            </tr>
            <tr>
              <td align="left">
                <bold>Medications in use (%)</bold>
              </td>
              <td align="center">
							</td>
              <td align="center">
							</td>
              <td align="center">
							</td>
              <td align="center">
							</td>
              <td align="center">
							</td>
            </tr>
            <tr>
              <td align="left">ACEI</td>
              <td align="center">33,3%</td>
              <td align="center">
							</td>
              <td align="center">31,7%</td>
              <td align="center">
							</td>
              <td align="center">1</td>
            </tr>
            <tr>
              <td align="left">ARB</td>
              <td align="center">20%</td>
              <td align="center">
							</td>
              <td align="center">46%</td>
              <td align="center">
							</td>
              <td align="center">0,084</td>
            </tr>
            <tr>
              <td align="left">Beta blocker</td>
              <td align="center">20%</td>
              <td align="center">
							</td>
              <td align="center">76,2%</td>
              <td align="center">
							</td>
              <td align="center">&lt; 0,001</td>
            </tr>
            <tr>
              <td align="left">Acetylsalicylic acid</td>
              <td align="center">60%</td>
              <td align="center">
							</td>
              <td align="center">87,3%</td>
              <td align="center">
							</td>
              <td align="center">0,023</td>
            </tr>
            <tr>
              <td align="left">Calcium channel blocker</td>
              <td align="center">26,7%</td>
              <td align="center">
							</td>
              <td align="center">34,9%</td>
              <td align="center">
							</td>
              <td align="center">0,762</td>
            </tr>
            <tr>
              <td align="left">Statin</td>
              <td align="center">53,3%</td>
              <td align="center">
							</td>
              <td align="center">82,5%</td>
              <td align="center">
							</td>
              <td align="center">0,035</td>
            </tr>
            <tr>
              <td align="left">Nitrate</td>
              <td align="center">40%</td>
              <td align="center">
							</td>
              <td align="center">36,5%</td>
              <td align="center">
							</td>
              <td align="center">1</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="TFN4">
            <p>BMI: body mass index; SBP: systolic blood pressure; HR: heart rate; LVEF: left ventricular ejection fraction; LA: measurement of the left atrium; LVFDD: left ventricular final diastolic diameter; LVFSD: left ventricular final systolic diameter; PASP: pulmonary artery systolic pressure. ACEI: angiotensinogen converting enzyme inhibitor; ARB: angiotensin receptor AT-2 blocker. Mann-Whitney was used for continuous variables (expressed in median and interquartile range) and Fisher's exact test for categorical variables (expressed as percentage).</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>Main causes to strain non-applicability were presence of prior infarction (56.4%), previous CTA (22.1%), prior surgical (CTA) revascularization (MRI), MRI and previous CTA (16, 7%), and presence of the following electrocardiographic alterations: LBBB, AF, pathological Q wave and pacemaker pace (12.8%).</p>
      <p>In group A, patient majority presented low or intermediate risk, as detailed in <xref ref-type="table" rid="t5">Table 5</xref>.</p>
      <table-wrap id="t5">
        <label>Table 5</label>
        <caption>
          <title>Risk score of patients submitted to longitudinal strain analysis</title>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup>
            <col width="50%"/>
            <col width="50%"/>
          </colgroup>
          <thead>
            <tr>
              <th align="left">Score</th>
              <th align="center">Frequency (%)</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left">
                <bold>GRACE</bold>
              </td>
              <td align="center">
							</td>
            </tr>
            <tr>
              <td align="left">&#8804; 108 points</td>
              <td align="center">86,7%</td>
            </tr>
            <tr>
              <td align="left">109-139 points</td>
              <td align="center">13,3%</td>
            </tr>
            <tr>
              <td align="left">&#8805; 140 points</td>
              <td align="center">0%</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="TFN5">
            <p>GRACE - Low risk - &#8804; 108, moderate risk - 109 to 139, &#8805; 140 - high risk</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>Coronary anatomy evaluation revealed a severe lesion in LMCA in 1 case (6.7%). Number of patients with severe lesions in coronary arteries AD, CX and RD was 2 (13.3%), 4 (26.7%) and 4 (26.7%), respectively.</p>
      <p>SL2D evaluation revealed a reduced global strain value in those who had severe lesion in any epicardial coronary artery (17.1 [3.1] versus 20.2 [6.7] with p = 0.014), area under the ROC curve 0.875, as shown in <xref ref-type="fig" rid="f2">Figures 2</xref> and <xref ref-type="fig" rid="f3">3</xref>.</p>
      <p>
        <fig id="f2">
          <label>Figure 2</label>
          <caption>
            <title>ROC curve to evaluate ability of global strain to identify severe lesion (&gt; 70%) in any epicardial coronary artery. Area under the ROC curve 0.875, with p &lt; 0.014.</title>
          </caption>
          <graphic xlink:href="1678-4170-abc-110-04-0354-80062-gf02.jpg"/></fig>
      </p>
      <p>
        <fig id="f3">
          <label>Figure 3</label>
          <caption>
            <title>Case of patient with unstable angina, anterior descending coronary artery with 90% lesion in the proximal third and circumflex coronary artery with lesion of 70% in the middle third.</title>
          </caption>
          <graphic xlink:href="1678-4170-abc-110-04-0354-80062-gf03.jpg"/></fig>
      </p>
      <p>Segmental strain assessment showed an association between severe CX lesion and longitudinal strain reduction of lateral wall basal segment (14 [5] versus 21 [10] with p = 0.04 and area under ROC curve = 0.864), and (12.5 [6] versus 19 [8] with p = 0.026 and area under ROC curve = 0.86).</p>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>Acquisition of images by ST with longitudinal strain determination allows a more complete myocardial function assessment and can detect subtle alterations in segmental contractility in ischemic heart disease patients, with good inter and intraobserver reproducibility.<xref ref-type="bibr" rid="B7">7</xref><sup>,</sup><xref ref-type="bibr" rid="B12">12</xref> Thus, this method has been gaining more space in coronary artery disease evaluation, with a large number of studies produced in recent years.<xref ref-type="bibr" rid="B15">15</xref><sup>-</sup><xref ref-type="bibr" rid="B17">17</xref>
			</p>
      <p>The present study is one of the pioneers in longitudinal strain applicability evaluation in UA patients attended at the Emergency Room of a Tertiary-level Cardiology Hospital.</p>
      <p>The studied population clinical, electrocardiographic and echocardiographic characteristics demonstrate the complexity of patients with coronary artery disease (CAD). This probably justifies the method low applicability, since there are many variables (existing in the majority of patients studied) that could impair detection of reduced deformity due to ischemia. We emphasize that in the study population, 56.1% had previous infarction and 44.6% had previous cardiac procedure (CTA, MRI or both).</p>
      <p>Shimoni et al.,<xref ref-type="bibr" rid="B18">18</xref> evaluated SL2D in 97 hospitalized patients with angina and normal ventricular function; of these, 69 patients had major coronary disease. Global strain analysis was -17.3 &#177; 2.4 with an area under the ROC curve (AUC) of 0.80 to identify significant CAD in patients with angina; in the subgroup of patients with unstable angina the global strain also demonstrated good accuracy in predicting angiographic obstructive CAD (AUC = 0.86).<xref ref-type="bibr" rid="B18">18</xref> Findings of this study are similar to those found in relation to strain diagnostic accuracy to identify significant CAD in angina , however, there was no reference as to method applicability to the sample.</p>
      <p>We verified in the present study a statistically significant association between reduced global strain values and the presence of anatomically severe CAD, and similar accuracy to data available in the literature.<xref ref-type="bibr" rid="B19">19</xref> When we analyzed segmental strain, we found a significant association only in basal segment deformity reduction of lateral and inferior walls, with stenosis &#8805; 70% in CX and RD coronaries, respectively. We believe that segmental strain findings would be more robust if the sample was larger.</p>
      <p>In a meta-analysis published in 2016 with 1385 patients included in 10 studies, global longitudinal strain demonstrated good accuracy in detecting moderate to severe CAD in symptomatic patients with AUC of 0.81, sensitivity of 74.4% and specificity of 72.1%.<xref ref-type="bibr" rid="B19">19</xref>
			</p>
      <p>Despite the low SL2D applicability in ER and CU, most probably due to patients profile that our institution attends, current evidence and our findings indicate that this method may be a complementary exam in diagnostic algorithm of CAD and useful tool in early ischemia evaluation.</p>
    </sec>
    <sec sec-type="conclusions">
      <title>Conclusion</title>
      <p>In 80.8% of the cases, it was not possible to apply longitudinal strain, mainly due to the following criteria: presence of previous infarction or prior revascularization (percutaneous or surgical). We believe that the method applicability in a profile of patients with less clinical complexity would be greater, due to the method technical limitations.</p>
      <p>In spite of this limitation, we can observe that the global strain showed a correlation with the presence of anatomically severe coronary lesion. In this way, SL2D could be included in the diagnostic arsenal of UA, in emergency units, since it is a noninvasive examination with diagnostic information available in a short period.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="financial-disclosure">
        <p>
          <bold>Sources of Funding</bold>
        </p>
        <p>There were no external funding sources for this study.</p>
      </fn>
      <fn fn-type="other">
        <p>
          <bold>Study Association</bold>
        </p>
        <p>This study is not associated with any thesis or dissertation work.</p>
      </fn>
      <fn fn-type="other">
        <p>
          <bold>Ethics approval and consent to participate</bold>
        </p>
        <p>This article does not contain any studies with human participants or animals performed by any of the authors.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <label>1</label>
        <mixed-citation>1 Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia. Circulation. 1994;89(4):1545-56. doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/01.CIR.89.4.1545">https://doi.org/10.1161/01.CIR.89.4.1545</ext-link>.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia</article-title>
          <source>Circulation</source>
          <year>1994</year>
          <volume>89</volume>
          <issue>4</issue>
          <fpage>1545</fpage>
          <lpage>1556</lpage>
          <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/01.CIR.89.4.1545">https://doi.org/10.1161/01.CIR.89.4.1545</ext-link>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <mixed-citation>2 Braunwald E. Unstable angina: a classification. Circulation. 1989;80(2):410-4. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/01.CIR.80.2.410">https://doi.org/10.1161/01.CIR.80.2.410</ext-link>.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Braunwald</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Unstable angina: a classification</article-title>
          <source>Circulation</source>
          <year>1989</year>
          <volume>80</volume>
          <issue>2</issue>
          <fpage>410</fpage>
          <lpage>414</lpage>
          <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/01.CIR.80.2.410">https://doi.org/10.1161/01.CIR.80.2.410</ext-link>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <mixed-citation>3 Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE, et al. 2012 ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;61(23):e179-347. doi: 10.1016/j.jacc.2013.01.014. Erratum in: J Am Coll Cardiol. 2013;62(11):1040-1.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Anderson</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Adams</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Antman</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Bridges</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Califf</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Casey</surname>
              <given-names>DE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>2012 ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines</article-title>
          <source>J Am Coll Cardiol</source>
          <year>2013</year>
          <volume>61</volume>
          <issue>23</issue>
          <elocation-id>e179-347</elocation-id>
          <pub-id pub-id-type="doi">10.1016/j.jacc.2013.01.014</pub-id>
          <comment>Erratum in: J Am Coll Cardiol. 2013;62(11):1040-1</comment>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <mixed-citation>4 Amundsen BH, Helle-Valle T, Edvardsen T, Torp H, Crosby J, Lyseggen E, et al. Noninvasive myocardial strain measurement by speckle tracking echocardiography; validation against sonomicrometry and tagged magnetic resonance imaging. J Am Coll Cardiol. 2006;47(4):789-93. doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jacc.2005.10.040">https://doi.org/10.1016/j.jacc.2005.10.040</ext-link>.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Amundsen</surname>
              <given-names>BH</given-names>
            </name>
            <name>
              <surname>Helle-Valle</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Edvardsen</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Torp</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Crosby</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lyseggen</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Noninvasive myocardial strain measurement by speckle tracking echocardiography; validation against sonomicrometry and tagged magnetic resonance imaging</article-title>
          <source>J Am Coll Cardiol</source>
          <year>2006</year>
          <volume>47</volume>
          <issue>4</issue>
          <fpage>789</fpage>
          <lpage>793</lpage>
          <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jacc.2005.10.040">https://doi.org/10.1016/j.jacc.2005.10.040</ext-link>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <mixed-citation>5 Choi JO, Cho SW, Song YB, Cho SJ, Song BG, Lee SC, et al. Longitudinal 2D strain at rest predicts the presence of left main and three vessel coronary artery disease in patients without regional wall motion abnormality. Eur J Echocardiogr. 2009;10(5):695-701. doi: 10.1093/ejechocard/jep041.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Choi</surname>
              <given-names>JO</given-names>
            </name>
            <name>
              <surname>Cho</surname>
              <given-names>SW</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>YB</given-names>
            </name>
            <name>
              <surname>Cho</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>BG</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>SC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Longitudinal 2D strain at rest predicts the presence of left main and three vessel coronary artery disease in patients without regional wall motion abnormality</article-title>
          <source>Eur J Echocardiogr</source>
          <year>2009</year>
          <volume>10</volume>
          <issue>5</issue>
          <fpage>695</fpage>
          <lpage>701</lpage>
          <pub-id pub-id-type="doi">10.1093/ejechocard/jep041</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <mixed-citation>6 Perk G, Tunick PA, Kronzon I. Non-Doppler two-dimensional strain imaging by echocardiography-from technical considerations to clinical applications. J Am Soc Echocardiogr. 2007;20(3):234-43. doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.echo.2006.08.023">http://dx.doi.org/10.1016/j.echo.2006.08.023</ext-link>.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Perk</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Tunick</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Kronzon</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Non-Doppler two-dimensional strain imaging by echocardiography-from technical considerations to clinical applications</article-title>
          <source>J Am Soc Echocardiogr</source>
          <year>2007</year>
          <volume>20</volume>
          <issue>3</issue>
          <fpage>234</fpage>
          <lpage>243</lpage>
          <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.echo.2006.08.023">http://dx.doi.org/10.1016/j.echo.2006.08.023</ext-link>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <mixed-citation>7 Geyer H, Caracciolo G, Abe H, Wilansky S, Carerj S, Gentile F, et al. Assessment of myocardial mechanics using speckle tracking echocardiography: fundamentals and clinical applications. J Am Soc Echocardiogr. 2010; 23(4):351-69. doi: 10.1016/j.echo.2010.02.015. Erratum in: J Am Soc Echocardiogr. 2010;23(7):734.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Geyer</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Caracciolo</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Abe</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Wilansky</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Carerj</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gentile</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Assessment of myocardial mechanics using speckle tracking echocardiography: fundamentals and clinical applications</article-title>
          <source>J Am Soc Echocardiogr</source>
          <year>2010</year>
          <volume>23</volume>
          <issue>4</issue>
          <fpage>351</fpage>
          <lpage>369</lpage>
          <pub-id pub-id-type="doi">10.1016/j.echo.2010.02.015</pub-id>
          <comment>Erratum in: J Am Soc Echocardiogr. 2010;23(7):734</comment>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <mixed-citation>8 Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, et al; Global Registry of Acute Coronary Events Investigators. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med. 2003;163 (19): 2345-53. doi: 10.1001/archinte.163.19.2345.</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Granger</surname>
              <given-names>CB</given-names>
            </name>
            <name>
              <surname>Goldberg</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Dabbous</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Pieper</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Eagle</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Cannon</surname>
              <given-names>CP</given-names>
            </name>
            <etal/>
            <collab>Global Registry of Acute Coronary Events Investigators</collab>
          </person-group>
          <chapter-title>Predictors of hospital mortality in the global registry of acute coronary events</chapter-title>
          <source>Arch Intern Med</source>
          <year>2003</year>
          <volume>163</volume>
          <issue>19</issue>
          <fpage>2345</fpage>
          <lpage>2353</lpage>
          <pub-id pub-id-type="doi">10.1001/archinte.163.19.2345</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <mixed-citation>9 Eagle KA, Lim MJ, Dabbous OH, Pieper KS, Goldberg RJ, Van de Werf F, et al; Grace Investigators. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA. 2004;291(22):2727-33. doi: 10.1001/jama.291.22.2727.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eagle</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Lim</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Dabbous</surname>
              <given-names>OH</given-names>
            </name>
            <name>
              <surname>Pieper</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Goldberg</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Van de Werf</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
            <collab>Grace Investigators</collab>
          </person-group>
          <article-title>A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry</article-title>
          <source>JAMA</source>
          <year>2004</year>
          <volume>291</volume>
          <issue>22</issue>
          <fpage>2727</fpage>
          <lpage>2733</lpage>
          <pub-id pub-id-type="doi">10.1001/jama.291.22.2727</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <mixed-citation>10 Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al; Chamber Quantification Writing Group; American Society of Echocardiography&#8217;s Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography&#8217;s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18(12):1440-1463. doi: 10.1016/j.echo.2005.10.005.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lang</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Bierig</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Devereux</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Flachskampf</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>Foster</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Pellikka</surname>
              <given-names>PA</given-names>
            </name>
            <etal/>
            <collab>Chamber Quantification Writing Group</collab>
            <collab>American Society of Echocardiography&#8217;s Guidelines and Standards Committee</collab>
            <collab>European Association of Echocardiography</collab>
          </person-group>
          <article-title>Recommendations for chamber quantification: a report from the American Society of Echocardiography&#8217;s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology</article-title>
          <source>J Am Soc Echocardiogr</source>
          <year>2005</year>
          <volume>18</volume>
          <issue>12</issue>
          <fpage>1440</fpage>
          <lpage>1463</lpage>
          <pub-id pub-id-type="doi">10.1016/j.echo.2005.10.005</pub-id>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <mixed-citation>11 Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Fleisher LA, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease. A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017;70(2):252-89. doi: 10.1016/j.jacc.2017.03.011.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nishimura</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Otto</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Bonow</surname>
              <given-names>RO</given-names>
            </name>
            <name>
              <surname>Carabello</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Erwin</surname>
              <given-names>JP</given-names>
              <suffix>3rd</suffix>
            </name>
            <name>
              <surname>Fleisher</surname>
              <given-names>LA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease. A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines</article-title>
          <source>J Am Coll Cardiol</source>
          <year>2017</year>
          <volume>70</volume>
          <issue>2</issue>
          <fpage>252</fpage>
          <lpage>289</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jacc.2017.03.011</pub-id>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <mixed-citation>12 Del Castillo JM, Herszkowicz N, Ferreira C. Speckle tracking-a contratilidade mioc&#225;rdica em sintonia fina. Rev bras ecocardiogr imagem cardiovasc. 2010;23(3):46-54.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Del Castillo</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Herszkowicz</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Ferreira</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Speckle tracking-a contratilidade mioc&#225;rdica em sintonia fina</article-title>
          <source>Rev bras ecocardiogr imagem cardiovasc</source>
          <year>2010</year>
          <volume>23</volume>
          <issue>3</issue>
          <fpage>46</fpage>
          <lpage>54</lpage>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <mixed-citation>13 Leitman M, Lysyansky P, Sidenko S, Shir V, Peleg E, Binenbaum M, et al. Two dimensional strain: a novel software for real-time quantitative echocardiographic assessment of myocardial function. J Am Soc Echocardiogr. 2004;17(10):1021-9. doi: 10.1016/j.echo.2004.06.019.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leitman</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lysyansky</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Sidenko</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Shir</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Peleg</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Binenbaum</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Two dimensional strain: a novel software for real-time quantitative echocardiographic assessment of myocardial function</article-title>
          <source>J Am Soc Echocardiogr</source>
          <year>2004</year>
          <volume>17</volume>
          <issue>10</issue>
          <fpage>1021</fpage>
          <lpage>1029</lpage>
          <pub-id pub-id-type="doi">10.1016/j.echo.2004.06.019</pub-id>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <mixed-citation>14 Nicolau JC, Timerman A, Marin-Neto JA, Piegas LS, Barbosa CJ, Franci A, et al; Sociedade Brasileira de Cardiologia. [Guidelines of Sociedade Brasileira de Cardiologia for unstable angina and non-ST-segment elevation myocardial infarction (II edition, 2007) 2013-2014 update]. Arq Bras Cardiol. 2014;102(3 Suppl 1):1-61. doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.5935/abc.2014S001">http://dx.doi.org/10.5935/abc.2014S001</ext-link>.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nicolau</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Timerman</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Marin-Neto</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Piegas</surname>
              <given-names>LS</given-names>
            </name>
            <name>
              <surname>Barbosa</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Franci</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
            <collab>Sociedade Brasileira de Cardiologia</collab>
          </person-group>
          <article-title>[Guidelines of Sociedade Brasileira de Cardiologia for unstable angina and non-ST-segment elevation myocardial infarction (II edition, 2007) 2013-2014 update]</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2014</year>
          <volume>102</volume>
          <issue>3</issue>
          <supplement>Suppl 1</supplement>
          <fpage>1</fpage>
          <lpage>61</lpage>
          <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.5935/abc.2014S001">http://dx.doi.org/10.5935/abc.2014S001</ext-link>
        </element-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <mixed-citation>15 Eek C, Grenne B, Brunvand H, Aakhus S, Endresen K, Smiseth AO, et al. Strain echocardiography predicts acute coronary occlusion in patients with non-ST-segment elevation acute coronary syndrome. Eur J Echocardiogr. 2010;11(6):501-8. doi: 10.1093/ejechocard/jeq008.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eek</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Grenne</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Brunvand</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Aakhus</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Endresen</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Smiseth</surname>
              <given-names>AO</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Strain echocardiography predicts acute coronary occlusion in patients with non-ST-segment elevation acute coronary syndrome</article-title>
          <source>Eur J Echocardiogr</source>
          <year>2010</year>
          <volume>11</volume>
          <issue>6</issue>
          <fpage>501</fpage>
          <lpage>508</lpage>
          <pub-id pub-id-type="doi">10.1093/ejechocard/jeq008</pub-id>
        </element-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <mixed-citation>16 Grenne B, Eek C, Sjoli B, Dahlslett T, Uchto M, Hol PK, et al. Acute coronary occlusion in non-ST-elevation acute coronary syndrome: outcome and early identification by strain echocardiography. Heart. 2010;96(19):1550-6. doi: 10.1136/hrt.2009.188391.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grenne</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Eek</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Sjoli</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Dahlslett</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Uchto</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hol</surname>
              <given-names>PK</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Acute coronary occlusion in non-ST-elevation acute coronary syndrome: outcome and early identification by strain echocardiography</article-title>
          <source>Heart</source>
          <year>2010</year>
          <volume>96</volume>
          <issue>19</issue>
          <fpage>1550</fpage>
          <lpage>1556</lpage>
          <pub-id pub-id-type="doi">10.1136/hrt.2009.188391</pub-id>
        </element-citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <mixed-citation>17 Dahlslett T, Karlsen S, Grenne S, Eek C, Sjoli B, Skulstad H, et al. Early assessment of strain echocardiography can accurately exclude significant coronary artery stenosis in suspect non-ST-segment elevation acute coronary syndrome. J Am Soc Echocardiogr. 2014;27(5):512-9. doi: 10.1016/j.echo.2014.01.019.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dahlslett</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Karlsen</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Grenne</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Eek</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Sjoli</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Skulstad</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Early assessment of strain echocardiography can accurately exclude significant coronary artery stenosis in suspect non-ST-segment elevation acute coronary syndrome</article-title>
          <source>J Am Soc Echocardiogr</source>
          <year>2014</year>
          <volume>27</volume>
          <issue>5</issue>
          <fpage>512</fpage>
          <lpage>519</lpage>
          <pub-id pub-id-type="doi">10.1016/j.echo.2014.01.019</pub-id>
        </element-citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <mixed-citation>18 Shimoni S, Gendelman G, Ayzenberg O, Smirin N, Lysyansky P, Edri O, et al. Differential effects of coronary artery stenosis on myocardial function: the value of myocardial strain analysis for the detection of coronary artery disease. J Am Soc Echocardiogr. 2011;24(7):748-57. doi: 10.1016/j.echo.2011.03.007.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shimoni</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gendelman</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Ayzenberg</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Smirin</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Lysyansky</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Edri</surname>
              <given-names>O</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Differential effects of coronary artery stenosis on myocardial function: the value of myocardial strain analysis for the detection of coronary artery disease</article-title>
          <source>J Am Soc Echocardiogr</source>
          <year>2011</year>
          <volume>24</volume>
          <issue>7</issue>
          <fpage>748</fpage>
          <lpage>757</lpage>
          <pub-id pub-id-type="doi">10.1016/j.echo.2011.03.007</pub-id>
        </element-citation>
      </ref>
      <ref id="B19">
        <label>19</label>
        <mixed-citation>19 Liou K, Negishi K, Ho S, Russell EA, Cranney G, Ooi SY. Detection of obstructive coronary artery disease using peak systolic global longitudinal strain derived by two-dimensional speckle-tracking: a systematic review and meta-analysis. J Am Soc Echocardiogr. 2016;29(8):724-35.e4. doi: 10.1016/j.echo.2016.03.002.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liou</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Negishi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ho</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Russell</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Cranney</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Ooi</surname>
              <given-names>SY</given-names>
            </name>
          </person-group>
          <article-title>Detection of obstructive coronary artery disease using peak systolic global longitudinal strain derived by two-dimensional speckle-tracking: a systematic review and meta-analysis</article-title>
          <source>J Am Soc Echocardiogr</source>
          <year>2016</year>
          <volume>29</volume>
          <issue>8</issue>
          <fpage>724</fpage>
          <lpage>735</lpage>
          <comment>e4</comment>
          <pub-id pub-id-type="doi">10.1016/j.echo.2016.03.002</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="s1" xml:lang="pt">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Artigos Originais</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Aplicabilidade do Strain Longitudinal do Ventr&#237;culo Esquerdo na Angina Inst&#225;vel</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Santos</surname>
            <given-names>Natasha Soares Sim&#245;es dos</given-names>
          </name>
          <xref ref-type="aff" rid="aff2"/>
          <xref ref-type="corresp" rid="c2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Vilela</surname>
            <given-names>Andrea de Andrade</given-names>
          </name>
          <xref ref-type="aff" rid="aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Barretto</surname>
            <given-names>Rodrigo Bellio de Mattos</given-names>
          </name>
          <xref ref-type="aff" rid="aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Vale</surname>
            <given-names>Marcela Paganelli do</given-names>
          </name>
          <xref ref-type="aff" rid="aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rezende</surname>
            <given-names>Mariana Oliveira</given-names>
          </name>
          <xref ref-type="aff" rid="aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ferreira</surname>
            <given-names>Murilo Castro</given-names>
          </name>
          <xref ref-type="aff" rid="aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Andrade</surname>
            <given-names>Alexandre Jos&#233; Aguiar</given-names>
          </name>
          <xref ref-type="aff" rid="aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Scorsioni</surname>
            <given-names>Nelson Henrique Goes</given-names>
          </name>
          <xref ref-type="aff" rid="aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Queiroga</surname>
            <given-names>Ol&#237;via Ximenes de</given-names>
          </name>
          <xref ref-type="aff" rid="aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bihan</surname>
            <given-names>David Le</given-names>
          </name>
          <xref ref-type="aff" rid="aff2"/>
        </contrib>
        <aff id="aff2">
          <institution content-type="original">Instituto Dante Pazzanese de Cardiologia, S&#227;o Paulo, SP - Brasil</institution>
        </aff>
      </contrib-group>
      <author-notes>
        <corresp id="c2"><bold>Correspond&#234;ncia: Natasha Soares Sim&#245;es dos Santos,</bold> Av. Dante Pazzanese, 500. CEP 04012-909, Vila Mariana, S&#227;o Paulo, SP - Brasil. E-mail: <email>natashasimoes@hotmail.com</email>, <email>mariananatasha@yahoo.com.br</email>
				</corresp>
        <fn fn-type="con">
          <p>
            <bold>Contribui&#231;&#227;o dos autores</bold>
          </p>
          <p>Concep&#231;&#227;o e desenho da pesquisa: Santos NSS, Vilela AA, Barretto RBM, Rezende MO, Ferreira MC, Andrade AJA, Scorsioni NHG, Queiroga OX, Le Bihan D; Obten&#231;&#227;o de dados: Santos NSS, Vilela AA, Vale MP, Rezende MO, Ferreira MC, Andrade AJA, Scorsioni NHG, Queiroga OX; An&#225;lise e interpreta&#231;&#227;o dos dados: Santos NSS, Vilela AA, Barretto RBM, Vale MP, Rezende MO, Ferreira MC, Andrade AJA, Scorsioni NHG, Queiroga OX, Le Bihan D; An&#225;lise estat&#237;stica e Revis&#227;o cr&#237;tica do manuscrito quanto ao conte&#250;do intelectual importante: Santos NSS, Vilela AA, Rezende MO, Ferreira MC, Andrade AJA, Scorsioni NHG, Queiroga OX; Obten&#231;&#227;o de financiamento e Reda&#231;&#227;o do manuscrito: Vilela AA.</p>
        </fn>
        <fn fn-type="conflict">
          <p>
            <bold>Potencial conflito de interesses</bold>
          </p>
          <p>Declaro n&#227;o haver conflito de interesses pertinentes.</p>
        </fn>
      </author-notes>
      <abstract>
        <title>Resumo</title>
        <sec>
          <title>Fundamento:</title>
          <p>A angina inst&#225;vel (AI) &#233; uma causa comum de interna&#231;&#227;o hospitalar, a estratifica&#231;&#227;o de risco ajuda a determinar estrat&#233;gias para o tratamento.</p>
        </sec>
        <sec>
          <title>Objetivo:</title>
          <p>Determinar a aplicabilidade do <italic>strain</italic> longitudinal bidimensional (SL2D) para identifica&#231;&#227;o de isquemia mioc&#225;rdica, em pacientes com AI.</p>
        </sec>
        <sec>
          <title>M&#233;todos:</title>
          <p>Estudo observacional transversal, descritivo, com dura&#231;&#227;o de 60 dias. A amostra foi composta por 78 pacientes, sendo quinze (19,2%) eleg&#237;veis para an&#225;lise do <italic>strain</italic> longitudinal. O valor de p &lt; 0.05 foi considerado significativo.</p>
        </sec>
        <sec>
          <title>Resultados:</title>
          <p>O grupo dos n&#227;o eleg&#237;veis apresentou: menor propor&#231;&#227;o de mulheres, maior preval&#234;ncia de diabetes mellitus (DM), do uso de AAS, estatinas e betabloqueadores e maiores di&#226;metros cavit&#225;rios. As principais causas da n&#227;o aplicabilidade foram: presen&#231;a de infarto pr&#233;vio (56,4%), ATC pr&#233;via (22,1%), RM pr&#233;via (11,5%) ou ambos (16,7%) e presen&#231;a de altera&#231;&#245;es eletrocardiogr&#225;ficas espec&#237;ficas (12,8%). A avalia&#231;&#227;o do SL2D revelou um valor de <italic>strain</italic> global inferior naqueles com estenose maior que 70% em alguma coron&#225;ria epic&#225;rdica (17,1 [3,1] versus 20,2 [6,7], com p = 0,014). A avalia&#231;&#227;o do <italic>strain</italic> segmentar demonstrou associa&#231;&#227;o entre les&#227;o grave nas coron&#225;rias CX e CD com redu&#231;&#227;o do <italic>strain</italic> longitudinal dos segmentos basais das paredes lateral e inferior; (14 [5] versus 21 [10], com p = 0,04) e (12,5 [6] versus 19 [8], com p = 0,026), respectivamente.</p>
        </sec>
        <sec>
          <title>Conclus&#227;o:</title>
          <p>Houve aplicabilidade muito baixa do SL2D para avaliar isquemia na popula&#231;&#227;o estudada. Entretanto, o <italic>strain</italic> global apresentou correla&#231;&#227;o com presen&#231;a de les&#227;o coron&#225;ria significativa, podendo, futuramente, ser inclu&#237;do no arsenal diagn&#243;stico da AI.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="pt">
        <title>Palavras-chave:</title>
        <kwd>Angina Inst&#225;vel / fisiopatologia</kwd>
        <kwd>Disfun&#231;&#227;o do Ventr&#237;culo Esquerdo</kwd>
        <kwd>Isquemia Mioc&#225;rdica / fisiopatologia</kwd>
        <kwd>Strain</kwd>
        <kwd>Ecocardiografia / m&#233;todos</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <sec sec-type="intro">
        <title>Introdu&#231;&#227;o</title>
        <p>Nos Estados Unidos a angina inst&#225;vel (AI) &#233; a causa cardiovascular mais comum de interna&#231;&#227;o hospitalar, sendo tamb&#233;m a respons&#225;vel pela maioria das interna&#231;&#245;es em unidades coronarianas.<xref ref-type="bibr" rid="B1">1</xref> O diagn&#243;stico de AI &#233; realizado por crit&#233;rios cl&#237;nicos baseados na dura&#231;&#227;o e intensidade da angina.<xref ref-type="bibr" rid="B2">2</xref> O paciente com AI tem progn&#243;stico vari&#225;vel quanto a eventos desfavor&#225;veis como infarto agudo do mioc&#225;rdio (IAM), recorr&#234;ncia de angina, biomarcadores de necrose, fun&#231;&#227;o ventricular e necessidade de revasculariza&#231;&#227;o mioc&#225;rdica.<xref ref-type="bibr" rid="B3">3</xref>
				</p>
        <p>O <italic>speckle tracking</italic> (ST) &#233; uma tecnologia introduzida na d&#233;cada de 80, que permite a quantifica&#231;&#227;o da deformidade mioc&#225;rdica global e regional por meio do rastreamento de &#8220;marcas ac&#250;sticas&#8221; naturais do m&#250;sculo card&#237;aco pelo ultrassom, apresentando valores reduzidos na presen&#231;a de isquemia mioc&#225;rdica.<xref ref-type="bibr" rid="B4">4</xref><sup>,</sup><xref ref-type="bibr" rid="B5">5</xref> O ST permite calcular o <italic>strain</italic> mioc&#225;rdico, e vem mostrando grande utilidade na identifica&#231;&#227;o de isquemia subendoc&#225;rdica, como ocorre na angina inst&#225;vel, com maior sensibilidade e especificidade que o ecocardiograma bidimensional.<xref ref-type="bibr" rid="B6">6</xref>
				</p>
        <p>Entretanto, para que o ST possa rastrear adequadamente os &#8220;<italic>speckles</italic>&#8221; existem algumas vari&#225;veis que podem interferir na an&#225;lise da deformidade, e por isso, quando est&#227;o presentes podem dar resultados err&#244;neos ou at&#233; impedir a an&#225;lise do <italic>strain</italic> mioc&#225;rdico. Al&#233;m disso, para a identifica&#231;&#227;o de isquemia mioc&#225;rdica em pacientes com AI, a presen&#231;a de infarto pr&#233;vio ou qualquer outra inj&#250;ria mioc&#225;rdica (como valvopatia importante), pode alterar a deformidade mioc&#225;rdica e provocar a an&#225;lise incorreta da verdadeira causa da diminui&#231;&#227;o de deformidade. Essas s&#227;o as vari&#225;veis que interferem na correta an&#225;lise da deformidade mioc&#225;rdica, e por esse motivo, s&#227;o consideradas crit&#233;rios de exclus&#227;o na grande maioria dos estudos (que objetivam analisar isquemia aguda) publicados: infarto pr&#233;vio, fibrila&#231;&#227;o atrial, bloqueio de ramo esquerdo, arritmia ventricular complexa, valvopatias a&#243;rtica e/ou mitral importante, cirurgia card&#237;aca pr&#233;via, hipertrofia ventricular, marcapasso card&#237;aco e janela ac&#250;stica inadequada.<xref ref-type="bibr" rid="B7">7</xref>
				</p>
        <p>O objetivo principal do presente estudo &#233; determinar a preval&#234;ncia da aplicabilidade do <italic>strain</italic> longitudinal bidimensional (SL2D) em todos os pacientes internados com diagn&#243;stico de AI, durante o per&#237;odo de observa&#231;&#227;o de 60 dias.</p>
        <p>O objetivo secund&#225;rio &#233; avaliar a capacidade diagn&#243;stica do SL2D na identifica&#231;&#227;o do vaso culpado pelo evento isqu&#234;mico nos pacientes com AI.</p>
      </sec>
      <sec sec-type="methods">
        <title>M&#233;todos</title>
        <p>Trata-se de estudo observacional transversal, descritivo, realizado no Pronto Socorro (PS) e Unidade Coronariana (UCO) do Instituto Dante Pazzanese de Cardiologia (IDPC).</p>
        <p>Os crit&#233;rios de inclus&#227;o foram: pacientes internados de ambos os sexos, idade maior que 18 anos e diagn&#243;stico cl&#237;nico de AI que foram admitidos no servi&#231;o do IDPC durante o per&#237;odo do estudo e aceitaram a participa&#231;&#227;o no mesmo, tendo assinado o termo de consentimento livre e esclarecido. Ressaltamos que n&#227;o houve c&#225;lculo do tamanho da amostra. Foi realizado o censo de todos os pacientes que tinham crit&#233;rio de inclus&#227;o. A chegada do paciente ao servi&#231;o do IDPC foi por conveni&#234;ncia.</p>
        <p>O crit&#233;rio de exclus&#227;o foi a mudan&#231;a do diagn&#243;stico durante a interna&#231;&#227;o. Esses casos ocorreram em pacientes que deram entrada no servi&#231;o com quadro inicial de dor precordial e ap&#243;s proped&#234;utica e exames complementares foi descartado o diagn&#243;stico de AI. Tratando-se de diagn&#243;stico diferencial e fechando como diagn&#243;stico final: infarto agudo do mioc&#225;rdio (IAM) com supra ou sem supra do segmento ST, dissec&#231;&#227;o a&#243;rtica, embolia pulmonar e estenose a&#243;rtica.</p>
        <p>Foram analisadas as caracter&#237;sticas cl&#237;nico-epidemiol&#243;gicas e eletrocardiogr&#225;ficas, al&#233;m da coleta de amostra sangu&#237;nea para dosagem de troponina I e creatinina.</p>
        <p>A estratifica&#231;&#227;o de risco foi feita utilizando o escore de risco GRACE.<xref ref-type="bibr" rid="B8">8</xref><sup>,</sup><xref ref-type="bibr" rid="B9">9</xref>
				</p>
        <p>A an&#225;lise eletrocardiogr&#225;fica foi realizada por 2 cardiologistas experientes; em caso de discord&#226;ncia quanto ao diagn&#243;stico, o tra&#231;ado seria analisado por servi&#231;o especializado em laudos eletrocardiogr&#225;ficos da institui&#231;&#227;o em que se realizou a pesquisa.</p>
        <p>O ecocardiograma transtor&#225;cico foi realizado em at&#233; 48 horas do &#250;ltimo epis&#243;dio de dor precordial do paciente no PS ou UCO. O equipamento destinado para a realiza&#231;&#227;o do exame foi o Vivid E9 da marca GE&#174; (<italic>General Electric Medical System, Norway</italic>) com transdutor &#8220;<italic>phased array</italic>&#8221; dotado de frequ&#234;ncia de emiss&#227;o de 3,5 <italic>megahertz</italic>. As imagens obtidas durante o exame foram adquiridas com harm&#244;nica, numa repeti&#231;&#227;o de quadros entre 50 e 70 quadros/segundo, na forma de clipes digitais (utilizando uma m&#233;dia de tr&#234;s ciclos consecutivos) e gravadas em CDs para posterior an&#225;lise numa esta&#231;&#227;o de trabalho, EchoPAC PC version 6.0.1&#174; (<italic>GE VingmedUltrasound</italic>).</p>
        <p>De acordo com as diretrizes do comit&#234; da Sociedade Americana de Ecocardiografia e Sociedade Europeia de Ecocardiografia, que padronizaram a aquisi&#231;&#227;o dos planos de cortes tomogr&#225;ficos obtidos durante a realiza&#231;&#227;o de exames ecocardiogr&#225;ficos, foram adquiridas por via transtor&#225;cica, com o paciente em dec&#250;bito lateral esquerdo e monitorizado com eletrocardiograma, imagens de ecocardiografia pelo Bidimensional Doppler espectral (puls&#225;til e cont&#237;nuo) e mapeamento com fluxo em cores.<xref ref-type="bibr" rid="B10">10</xref>
				</p>
        <p>Medidas adquiridas:</p>
        <p>
          <list list-type="bullet">
            <list-item>
              <p>Bidimensional: Di&#226;metro diast&#243;lico e sist&#243;lico do ventr&#237;culo esquerdo (VE), di&#226;metro &#226;ntero-posterior do &#225;trio esquerdo (AE), di&#226;metro da raiz da aorta, espessura do septo interventricular e da parede posterior. Volume diast&#243;lico e sist&#243;lico do VE. C&#225;lculo da fra&#231;&#227;o de eje&#231;&#227;o (FE) pelo m&#233;todo de Simpson biplanar modificado do VE.</p>
            </list-item>
            <list-item>
              <p>Doppler e Mapeamento de Fluxo em Cores: Fluxo mitral com Doppler espectral (puls&#225;til e cont&#237;nuo) para an&#225;lise da fun&#231;&#227;o diast&#243;lica e quantifica&#231;&#227;o de valvopatia mitral, quando presente. Fluxo a&#243;rtico com Doppler espectral (puls&#225;til e cont&#237;nuo), para determina&#231;&#227;o da abertura e fechamento da valva a&#243;rtica (marcar o evento sist&#243;lico), e quantifica&#231;&#227;o de valvopatia a&#243;rtica, quando presente. O diagn&#243;stico e a quantifica&#231;&#227;o das les&#245;es valvares seguiram as recomenda&#231;&#245;es da Sociedade Americana de Ecocardiografia.<xref ref-type="bibr" rid="B11">11</xref>
							</p>
            </list-item>
          </list>
        </p>
        <p>A t&#233;cnica para obten&#231;&#227;o do <italic>strain</italic> longitudinal foi feita da seguinte maneira:</p>
        <p>
          <list list-type="bullet">
            <list-item>
              <p>Marca&#231;&#227;o do evento sist&#243;lico por meio do Doppler puls&#225;til do fluxo a&#243;rtico.</p>
            </list-item>
            <list-item>
              <p>Determina&#231;&#227;o de tr&#234;s pontos da borda endoc&#225;rdica em cada uma das seguintes imagens: apical 3 c&#226;maras (na base da parede anterosseptal, na base da parede inferolateral e no &#225;pice), apical 4 c&#226;maras (na base do septo, na base da parede lateral e no &#225;pice) e apical 2 c&#226;maras (na base da parede inferior, na base da parede anterior e no &#225;pice).</p>
            </list-item>
            <list-item>
              <p>Por meio da ferramenta <italic>Automatic Function Imaging</italic>&#174; (AFI), foi calculada, automaticamente, a deforma&#231;&#227;o de cada um dos 17 segmentos mioc&#225;rdicos, fornecendo, posteriormente, a deforma&#231;&#227;o global do ventr&#237;culo esquerdo (que &#233; a m&#233;dia dos segmentos analisados). O programa fornece as curvas do SL2D e o mapa polar com os valores do <italic>strain</italic> longitudinal em cada segmento.</p>
            </list-item>
          </list>
        </p>
        <p>Foi definido como pico sist&#243;lico o m&#225;ximo valor absoluto da curva do <italic>strain</italic> bidimensional. Foram definidos como territ&#243;rio isqu&#234;mico os segmentos mioc&#225;rdicos adjacentes com valor de <italic>strain</italic> alterado, correlacionando-os com a irriga&#231;&#227;o coron&#225;ria, conforme o mapa polar demonstrado na <xref ref-type="fig" rid="f4">Figura 1</xref>.</p>
        <p>
          <fig id="f4">
            <label>Figura 1</label>
            <caption>
              <title>Mapa Polar com a correla&#231;&#227;o da irriga&#231;&#227;o coron&#225;ria. DA: art&#233;ria coron&#225;ria descendente anterior; CX: art&#233;ria coron&#225;ria circunflexa; CD: art&#233;ria coron&#225;ria direita.</title>
            </caption>
            <graphic xlink:href="1678-4170-abc-110-04-0354-80062-gf01-pt.jpg"/></fig>
        </p>
        <p>Segundo a literatura,<xref ref-type="bibr" rid="B7">7</xref><sup>,</sup><xref ref-type="bibr" rid="B12">12</xref><sup>,</sup><xref ref-type="bibr" rid="B13">13</xref> as situa&#231;&#245;es citadas abaixo podem gerar altera&#231;&#227;o da deformidade mioc&#225;rdica, ou por real preju&#237;zo da deformidade, ou por limita&#231;&#227;o do <italic>software</italic> para identificar as marcas ac&#250;sticas durante o ciclo card&#237;aco:</p>
        <p>
          <list list-type="bullet">
            <list-item>
              <p>Hipertrofia ventricular (HVE) conc&#234;ntrica;</p>
            </list-item>
            <list-item>
              <p>Valvopatias a&#243;rtica e/ou mitral de grau maior que moderado;</p>
            </list-item>
            <list-item>
              <p>Ritmo de marca-passo;</p>
            </list-item>
            <list-item>
              <p>Pelo menos uma das seguintes altera&#231;&#245;es eletrocardiogr&#225;ficas: bloqueio de ramo esquerdo (BRE), ritmo de fibrila&#231;&#227;o atrial (FA) e arritmia ventricular complexa;</p>
            </list-item>
            <list-item>
              <p>Angina inst&#225;vel secund&#225;ria (anemia aguda, taquiarritmia e infec&#231;&#227;o);</p>
            </list-item>
            <list-item>
              <p>IAM pr&#233;vio ou procedimento de revasculariza&#231;&#227;o mioc&#225;rdica (percut&#226;nea ou cir&#250;rgica) pr&#233;vio e;</p>
            </list-item>
            <list-item>
              <p>Janela ac&#250;stica inadequada.</p>
            </list-item>
          </list>
        </p>
        <p>Baseado no exposto, formulamos a hip&#243;tese de que a presen&#231;a de uma dessas altera&#231;&#245;es citadas pode prejudicar &#224; an&#225;lise do SL2D na identifica&#231;&#227;o da doen&#231;a coron&#225;ria grave em pacientes com AI. Tais conceitos s&#227;o de fundamental import&#226;ncia para o conhecimento da real aplicabilidade do SL2D nessa popula&#231;&#227;o, quando o intuito do exame for avaliar doen&#231;a coron&#225;ria respons&#225;vel pelo quadro agudo.</p>
        <p>Pacientes eleg&#237;veis para a realiza&#231;&#227;o de ecocardiograma bidimensional com <italic>strain</italic> longitudinal foram submetidos ao m&#233;todo por dois profissionais habilitados e experientes, que n&#227;o tinham acesso as informa&#231;&#245;es quanto &#224; anatomia coron&#225;ria dos avaliados at&#233; a conclus&#227;o da pesquisa.</p>
        <p>Os resultados dos exames de cateterismo card&#237;aco (CATE) e Angiografia Coron&#225;ria por Tomografia Computadorizada (CCTA) tamb&#233;m foram analisados. Foi considerada les&#227;o grave estenose maior ou igual a 70% nas coron&#225;rias epic&#225;rdicas ou estenose maior ou igual a 50% em tronco da coron&#225;ria esquerda (TCE).</p>
        <p>A amostra foi dividida em dois grupos: Grupo A- pacientes em que foi poss&#237;vel a an&#225;lise pelo SL2D e Grupo B- pacientes em que n&#227;o foi poss&#237;vel a an&#225;lise pelo SL2D.</p>
        <p>O protocolo de pesquisa foi submetido e aprovado pelo Comit&#234; de &#201;tica e Pesquisa da Institui&#231;&#227;o.</p>
        <p>N&#227;o houve interfer&#234;ncia na conduta m&#233;dica individual em decorr&#234;ncia da participa&#231;&#227;o no estudo. Tal conduta foi baseada na rotina do PS e UCO que corresponde &#224;s diretrizes norte-americanas e nacionais<xref ref-type="bibr" rid="B3">3</xref><sup>,</sup><xref ref-type="bibr" rid="B14">14</xref> para o tratamento de pacientes com AI.</p>
        <sec>
          <title>An&#225;lise estat&#237;stica</title>
          <p>A an&#225;lise estat&#237;stica foi feita com o programa <italic>Statistical Package for Social Sciences</italic> (SPSS) vers&#227;o 19.0.</p>
          <p>Foram realizados os testes de Kolmogorov-Smirnov e Shapiro-Wilk para verifica&#231;&#227;o de distribui&#231;&#227;o normal da nossa amostra. Como a hip&#243;tese de normalidade foi rejeitada usamos testes n&#227;o param&#233;tricos para an&#225;lise.</p>
          <p>Os grupos foram comparados utilizando-se o teste de Mann-Whitney e o teste exato de Fisher conforme adequa&#231;&#227;o.</p>
          <p>As vari&#225;veis cont&#237;nuas foram apresentadas como mediana e intervalo interquartil e as vari&#225;veis categ&#243;ricas foram expressas em porcentagem (%).</p>
          <p>Foi feita a curva ROC para avaliar o poder discriminativo do SL2D na identifica&#231;&#227;o de estenose coronariana grave (&#8805; 70%) nos pacientes com AI.</p>
          <p>O n&#237;vel de signific&#226;ncia adotado foi de 5%.</p>
        </sec>
      </sec>
      <sec sec-type="results">
        <title>Resultados</title>
        <p>Foram avaliados 93 pacientes com diagn&#243;stico de AI na admiss&#227;o no PS; entretanto, quinze (16,2%) pacientes foram exclu&#237;dos da pesquisa por mudan&#231;a de diagn&#243;stico durante a interna&#231;&#227;o, sendo 13 (14%) casos com IAM sem supra do segmento ST, um (1,1%) com AI p&#243;s IAM e um (1,1%) caso com dissec&#231;&#227;o a&#243;rtica do tipo A.</p>
        <p>No final 78 pacientes com AI foram pesquisados, sendo quinze (19,2%) eleg&#237;veis para an&#225;lise do <italic>strain</italic> longitudinal.</p>
        <p>As principais caracter&#237;sticas cl&#237;nicas da popula&#231;&#227;o est&#227;o sumarizadas na <xref ref-type="table" rid="t6">tabela 1</xref>.</p>
        <table-wrap id="t6">
          <label>Tabela 1</label>
          <caption>
            <title>Caracter&#237;sticas cl&#237;nicas da popula&#231;&#227;o estudada (n = 78)</title>
          </caption>
          <table frame="hsides" rules="groups">
            <colgroup>
              <col width="50%"/>
              <col width="50%"/>
            </colgroup>
            <thead>
              <tr>
                <th align="left">
								</th>
                <th align="center">Mediana [p25- 75]</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left">Idade (anos)</td>
                <td align="center">61,5 [53 - 69]</td>
              </tr>
              <tr>
                <td align="left">
                  <bold>G&#234;nero (%)</bold>
                </td>
                <td align="center">
								</td>
              </tr>
              <tr>
                <td align="left">Masculino</td>
                <td align="center">60,3%</td>
              </tr>
              <tr>
                <td align="left">Feminino</td>
                <td align="center">39,4%</td>
              </tr>
              <tr>
                <td align="left">IMC (Kg/m<sup>2</sup>)</td>
                <td align="center">28,16 [24,47 - 30,71]</td>
              </tr>
              <tr>
                <td align="left">PAS (mmHg)</td>
                <td align="center">137 [122,75 - 154,25]</td>
              </tr>
              <tr>
                <td align="left">FC (bpm)</td>
                <td align="center">74 [69 - 83,5]</td>
              </tr>
              <tr>
                <td align="left">Creatinina s&#233;rica (mg/dL)</td>
                <td align="center">0,9 [0,7 - 1,1]</td>
              </tr>
              <tr>
                <td align="left">GRACE (pontos)</td>
                <td align="center">95 [81 - 117]</td>
              </tr>
              <tr>
                <td align="left">Troponina (pg/mL)</td>
                <td align="center">0,02 [0,01 - 0,05]</td>
              </tr>
              <tr>
                <td align="left">Hipertens&#227;o arterial (%)</td>
                <td align="center">88,5%</td>
              </tr>
              <tr>
                <td align="left">Diabetes (%)</td>
                <td align="center">38,5%</td>
              </tr>
              <tr>
                <td align="left">Tabagismo (%)</td>
                <td align="center">32,1%</td>
              </tr>
              <tr>
                <td align="left">Dislipidemia (%)</td>
                <td align="center">65,4%</td>
              </tr>
              <tr>
                <td align="left">Hist&#243;ria familiar para DAC (%)</td>
                <td align="center">19,2%</td>
              </tr>
              <tr>
                <td align="left">DAC conhecida (%)</td>
                <td align="center">66,7%</td>
              </tr>
              <tr>
                <td align="left">
                  <bold>Medica&#231;&#245;es em uso (%)</bold>
                </td>
                <td align="center">
								</td>
              </tr>
              <tr>
                <td align="left">IECA</td>
                <td align="center">32,1%</td>
              </tr>
              <tr>
                <td align="left">BRA</td>
                <td align="center">41%</td>
              </tr>
              <tr>
                <td align="left">Betabloqueador</td>
                <td align="center">65,4%</td>
              </tr>
              <tr>
                <td align="left">&#193;cido acetilsalic&#237;lico</td>
                <td align="center">82,1%</td>
              </tr>
              <tr>
                <td align="left">Outros antiplaquet&#225;rios</td>
                <td align="center">29,5%</td>
              </tr>
              <tr>
                <td align="left">Bloqueador dos canais de c&#225;lcio</td>
                <td align="center">33,3%</td>
              </tr>
              <tr>
                <td align="left">Estatina</td>
                <td align="center">76,9%</td>
              </tr>
              <tr>
                <td align="left">Nitrato</td>
                <td align="center">37,2%</td>
              </tr>
              <tr>
                <td align="left">
                  <bold>Interven&#231;&#227;o pr&#233;via (%)</bold>
                </td>
                <td align="center">
								</td>
              </tr>
              <tr>
                <td align="left">Revasculariza&#231;&#227;o cir&#250;rgica</td>
                <td align="center">11,5%</td>
              </tr>
              <tr>
                <td align="left">Angioplastia</td>
                <td align="center">22,1%</td>
              </tr>
              <tr>
                <td align="left">Angioplastia + revasculariza&#231;&#227;o cir&#250;rgica</td>
                <td align="center">16,7%</td>
              </tr>
              <tr>
                <td align="left">IAM pr&#233;vio (%)</td>
                <td align="center">56,4%</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="TFN6">
              <p>IMC: &#237;ndice de massa corp&#243;rea; PAS: press&#227;o arterial sist&#243;lica; FC: frequ&#234;ncia card&#237;aca; DAC: doen&#231;a arterial coronariana; IAM: infarto agudo do mioc&#225;rdio; IECA: inibidor da enzima conversora do angiotensinog&#234;nio; BRA: bloqueador do receptor AT-2 da angiotensina.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>Cerca de 70% da amostra n&#227;o apresentava altera&#231;&#227;o na dura&#231;&#227;o ou morfologia do complexo QRS; mais da metade (60,3%) n&#227;o mostrou altera&#231;&#227;o na repolariza&#231;&#227;o ventricular. Cinco pacientes (6,4%) apresentaram infradesnivelamento do segmento ST na admiss&#227;o. As principais altera&#231;&#245;es eletrocardiogr&#225;ficas encontram-se detalhadas na <xref ref-type="table" rid="t7">Tabela 2</xref>.</p>
        <table-wrap id="t7">
          <label>Tabela 2</label>
          <caption>
            <title>Achados eletrocardiogr&#225;ficos (n = 78)</title>
          </caption>
          <table frame="hsides" rules="groups">
            <colgroup>
              <col width="50%"/>
              <col width="50%"/>
            </colgroup>
            <thead>
              <tr>
                <th align="left">Altera&#231;&#227;o</th>
                <th align="center">Frequ&#234;ncia (%)</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left">DCRE</td>
                <td align="center">10,3%</td>
              </tr>
              <tr>
                <td align="left">BRD</td>
                <td align="center">3,8%</td>
              </tr>
              <tr>
                <td align="left">BDASE</td>
                <td align="center">2,6%</td>
              </tr>
              <tr>
                <td align="left">BRD + BDASE</td>
                <td align="center">2,6%</td>
              </tr>
              <tr>
                <td align="left">BRE</td>
                <td align="center">3,8%</td>
              </tr>
              <tr>
                <td align="left">Onda Q patol&#243;gica</td>
                <td align="center">3,8%</td>
              </tr>
              <tr>
                <td align="left">Ritmo de marcapasso</td>
                <td align="center">3,8%</td>
              </tr>
              <tr>
                <td align="left">FA alta resposta</td>
                <td align="center">1,3%</td>
              </tr>
              <tr>
                <td align="left">ARV anterosseptal</td>
                <td align="center">5,1%</td>
              </tr>
              <tr>
                <td align="left">ARV anterior</td>
                <td align="center">5,1%</td>
              </tr>
              <tr>
                <td align="left">ARV inferior</td>
                <td align="center">9%</td>
              </tr>
              <tr>
                <td align="left">ARV lateral</td>
                <td align="center">7,7%</td>
              </tr>
              <tr>
                <td align="left">ARV difusa</td>
                <td align="center">11,5%</td>
              </tr>
              <tr>
                <td align="left">Infra/ST &gt; 0,5 mm</td>
                <td align="center">1,3%</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="TFN7">
              <p>DCRE: dist&#250;rbio de condu&#231;&#227;o pelo ramo esquerdo; BRD: bloqueio de ramo direito; BDASE: bloqueio divisional anterossuperior esquerdo; ARV: altera&#231;&#227;o de repolariza&#231;&#227;o ventricular. FA: fibrila&#231;&#227;o atrial; BRE: bloqueio de ramo esquerdo.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>Dos 63 pacientes em que o <italic>strain</italic> longitudinal n&#227;o foi aplicado, 40 (63,5%) realizaram ecocardiografia bidimensional durante a perman&#234;ncia no PS. Os principais achados ecocardiogr&#225;ficos dessa popula&#231;&#227;o, incluindo os quinze pacientes submetidos ao SL2D, encontram-se na <xref ref-type="table" rid="t8">Tabela 3</xref>.</p>
        <table-wrap id="t8">
          <label>Tabela 3</label>
          <caption>
            <title>Achados ecocardiogr&#225;ficos (n = 55)</title>
          </caption>
          <table frame="hsides" rules="groups">
            <colgroup>
              <col width="50%"/>
              <col width="50%"/>
            </colgroup>
            <thead>
              <tr>
                <th align="left">Vari&#225;vel</th>
                <th align="center">Mediana [p25 - p75]</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left">FEVE Simpson</td>
                <td align="center">0,59 [0,5 - 0,65]</td>
              </tr>
              <tr>
                <td align="left">AE (mm)</td>
                <td align="center">39 [36 - 42]</td>
              </tr>
              <tr>
                <td align="left">DDFVE (mm)</td>
                <td align="center">51 [48 - 56]</td>
              </tr>
              <tr>
                <td align="left">DSFVE (mm)</td>
                <td align="center">32 [30 - 37,75]</td>
              </tr>
              <tr>
                <td align="left">Septo (mm)</td>
                <td align="center">10 [9 - 11]</td>
              </tr>
              <tr>
                <td align="left">Parede posterior (mm)</td>
                <td align="center">9 [9 - 11]</td>
              </tr>
              <tr>
                <td align="left">&#205;ndice de massa (g/m<sup>2</sup>)</td>
                <td align="center">124,5 [110 - 153,5]</td>
              </tr>
              <tr>
                <td align="left">PSAP (mmHg)</td>
                <td align="center">32 [31 - 36]</td>
              </tr>
              <tr>
                <td align="left">Raiz da aorta (mm)</td>
                <td align="center">34 [31 - 36]</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="TFN8">
              <p>FEVE: fra&#231;&#227;o de eje&#231;&#227;o do ventr&#237;culo esquerdo; AE: medida do &#225;trio esquerdo; DDFVE: di&#226;metro diast&#243;lico final do ventr&#237;culo esquerdo; DSFVE: di&#226;metro sist&#243;lico final do ventr&#237;culo esquerdo; PSAP: press&#227;o sist&#243;lica de art&#233;ria pulmonar.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>No total, 50 pacientes completaram a investiga&#231;&#227;o com CATE e cinco com CCTA. No primeiro exame, tr&#234;s pacientes apresentavam les&#227;o grave de TCE (3,9%), 22 (28,2%) de coron&#225;ria descendente anterior (DA), 21 (26,9%) de coron&#225;ria direita (CD) e 22 (28,2%) de coron&#225;ria circunflexa (CX). Nos pacientes submetidos a CCTA, um apresentava les&#227;o grave de DA (1,3%) e um em CD (1,3%).</p>
        <p>Durante a interna&#231;&#227;o, 23 pacientes (29,5%) foram submetidos a interven&#231;&#227;o. A principal terapia de revasculariza&#231;&#227;o foi a angioplastia transluminal coron&#225;ria (ATC). Em tr&#234;s casos (3,8%) a revasculariza&#231;&#227;o foi cir&#250;rgica.</p>
        <p>Comparando os pacientes eleg&#237;veis para an&#225;lise do <italic>strain</italic> longitudinal (grupo A) com os n&#227;o eleg&#237;veis (grupo B), verificamos que o grupo B apresentou uma menor propor&#231;&#227;o de mulheres, maior preval&#234;ncia de diabetes, maiores dimens&#245;es das cavidades esquerdas, maior di&#226;metro da raiz da aorta e menor fun&#231;&#227;o sist&#243;lica ao ecocardiograma bidimensional; al&#233;m de maior taxa de uso de AAS, estatinas e betabloqueadores, conforme os dados da <xref ref-type="table" rid="t9">Tabela 4</xref>.</p>
        <table-wrap id="t9">
          <label>Tabela 4</label>
          <caption>
            <title>Caracter&#237;sticas cl&#237;nicas e ecocardiogr&#225;ficas dos pacientes submetidos &#224; an&#225;lise do <italic>strain</italic> longitudinal (grupo A, n = 15), em compara&#231;&#227;o aos n&#227;o submetidos (grupo B, n = 63)</title>
          </caption>
          <table frame="hsides" rules="groups">
            <colgroup>
              <col width="16%"/>
              <col width="16%"/>
              <col width="16%"/>
              <col width="16%"/>
              <col width="16%"/>
              <col width="16%"/>
            </colgroup>
            <thead>
              <tr>
                <th align="left" rowspan="2">
								</th>
                <th align="center" colspan="2" style="border-bottom-width:thin;border-bottom-style:solid">Grupo A</th>
                <th align="center" colspan="2" style="border-bottom-width:thin;border-bottom-style:solid">Grupo B</th>
                <th align="center" rowspan="2">Valor de p</th>
              </tr>
              <tr>
                <th align="center">Mediana</th>
                <th align="center">Intervalo interquartil</th>
                <th align="center">Mediana</th>
                <th align="center">Intervalo interquartil</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left">Idade (anos)</td>
                <td align="center">57</td>
                <td align="center">16</td>
                <td align="center">62</td>
                <td align="center">16</td>
                <td align="center">0,899</td>
              </tr>
              <tr>
                <td align="left">
                  <bold>G&#234;nero (%)</bold>
                </td>
                <td align="center">
								</td>
                <td align="center">
								</td>
                <td align="center">
								</td>
                <td align="center">
								</td>
                <td align="center">
								</td>
              </tr>
              <tr>
                <td align="left">Masculino</td>
                <td align="center">33,3%</td>
                <td align="center">
								</td>
                <td align="center">66,7%</td>
                <td align="center">
								</td>
                <td align="center" rowspan="2">0,037</td>
              </tr>
              <tr>
                <td align="left">Feminino</td>
                <td align="center">66,7%</td>
                <td align="center">
								</td>
                <td align="center">33,3%</td>
                <td align="center">
								</td>
              </tr>
              <tr>
                <td align="left">IMC (Kg/m<sup>2</sup>)</td>
                <td align="center">28,62</td>
                <td align="center">7,2</td>
                <td align="center">28,12</td>
                <td align="center">6,56</td>
                <td align="center">0,903</td>
              </tr>
              <tr>
                <td align="left">PAS (mmHg)</td>
                <td align="center">143</td>
                <td align="center">33</td>
                <td align="center">137</td>
                <td align="center">31</td>
                <td align="center">0,510</td>
              </tr>
              <tr>
                <td align="left">FC (bpm)</td>
                <td align="center">78</td>
                <td align="center">23</td>
                <td align="center">74</td>
                <td align="center">14</td>
                <td align="center">0,824</td>
              </tr>
              <tr>
                <td align="left">Creatinina (mg/dL)</td>
                <td align="center">0,7</td>
                <td align="center">0,5</td>
                <td align="center">0,9</td>
                <td align="center">0,3</td>
                <td align="center">0,127</td>
              </tr>
              <tr>
                <td align="left">GRACE (pontos)</td>
                <td align="center">94</td>
                <td align="center">27</td>
                <td align="center">97</td>
                <td align="center">36</td>
                <td align="center">0,287</td>
              </tr>
              <tr>
                <td align="left">Hipertens&#227;o arterial (%)</td>
                <td align="center">80%</td>
                <td align="center">
								</td>
                <td align="center">90,5%</td>
                <td align="center">
								</td>
                <td align="center">0,363</td>
              </tr>
              <tr>
                <td align="left">Diabetes (%)</td>
                <td align="center">13,3%</td>
                <td align="center">
								</td>
                <td align="center">44,4%</td>
                <td align="center">
								</td>
                <td align="center">0,037</td>
              </tr>
              <tr>
                <td align="left">Tabagismo (%)</td>
                <td align="center">33,3%</td>
                <td align="center">
								</td>
                <td align="center">31,7%</td>
                <td align="center">
								</td>
                <td align="center">1</td>
              </tr>
              <tr>
                <td align="left">Dislipidemia (%)</td>
                <td align="center">60%</td>
                <td align="center">
								</td>
                <td align="center">66,7%</td>
                <td align="center">
								</td>
                <td align="center">0,764</td>
              </tr>
              <tr>
                <td align="left">Hist&#243;ria familiar para DAC (%)</td>
                <td align="center">26,7%</td>
                <td align="center">
								</td>
                <td align="center">17,5%</td>
                <td align="center">
								</td>
                <td align="center">0,470</td>
              </tr>
              <tr>
                <td align="left">FEVE Simpson</td>
                <td align="center">0,65</td>
                <td align="center">0,08</td>
                <td align="center">0,55</td>
                <td align="center">0,18</td>
                <td align="center">0,006</td>
              </tr>
              <tr>
                <td align="left">AE (mm)</td>
                <td align="center">37</td>
                <td align="center">5</td>
                <td align="center">40</td>
                <td align="center">9</td>
                <td align="center">0,009</td>
              </tr>
              <tr>
                <td align="left">DDFVE (mm)</td>
                <td align="center">48</td>
                <td align="center">5</td>
                <td align="center">53,5</td>
                <td align="center">9</td>
                <td align="center">0,007</td>
              </tr>
              <tr>
                <td align="left">DSFVE (mm)</td>
                <td align="center">31</td>
                <td align="center">6</td>
                <td align="center">37</td>
                <td align="center">7</td>
                <td align="center">0,112</td>
              </tr>
              <tr>
                <td align="left">Septo (mm)</td>
                <td align="center">10</td>
                <td align="center">2</td>
                <td align="center">10</td>
                <td align="center">3</td>
                <td align="center">0,668</td>
              </tr>
              <tr>
                <td align="left">Parede posterior (mm)</td>
                <td align="center">9</td>
                <td align="center">1</td>
                <td align="center">10</td>
                <td align="center">2</td>
                <td align="center">0,118</td>
              </tr>
              <tr>
                <td align="left">&#205;ndice de massa (g/m<sup>2</sup>)</td>
                <td align="center">109</td>
                <td align="center">49</td>
                <td align="center">133,5</td>
                <td align="center">26</td>
                <td align="center">0,095</td>
              </tr>
              <tr>
                <td align="left">PSAP (mmHg)</td>
                <td align="center">34</td>
                <td align="center">13</td>
                <td align="center">29,5</td>
                <td align="center">10</td>
                <td align="center">0,895</td>
              </tr>
              <tr>
                <td align="left">Raiz da aorta (mm)</td>
                <td align="center">31</td>
                <td align="center">4</td>
                <td align="center">35</td>
                <td align="center">4</td>
                <td align="center">0,006</td>
              </tr>
              <tr>
                <td align="left">
                  <bold>Medica&#231;&#245;es em uso (%)</bold>
                </td>
                <td align="center">
								</td>
                <td align="center">
								</td>
                <td align="center">
								</td>
                <td align="center">
								</td>
                <td align="center">
								</td>
              </tr>
              <tr>
                <td align="left">IECA</td>
                <td align="center">33,3%</td>
                <td align="center">
								</td>
                <td align="center">31,7%</td>
                <td align="center">
								</td>
                <td align="center">1</td>
              </tr>
              <tr>
                <td align="left">BRA</td>
                <td align="center">20%</td>
                <td align="center">
								</td>
                <td align="center">46%</td>
                <td align="center">
								</td>
                <td align="center">0,084</td>
              </tr>
              <tr>
                <td align="left">Betabloqueador</td>
                <td align="center">20%</td>
                <td align="center">
								</td>
                <td align="center">76,2%</td>
                <td align="center">
								</td>
                <td align="center">&lt; 0,001</td>
              </tr>
              <tr>
                <td align="left">&#193;cido acetilsalic&#237;lico</td>
                <td align="center">60%</td>
                <td align="center">
								</td>
                <td align="center">87,3%</td>
                <td align="center">
								</td>
                <td align="center">0,023</td>
              </tr>
              <tr>
                <td align="left">Bloqueador dos canais de c&#225;lcio</td>
                <td align="center">26,7%</td>
                <td align="center">
								</td>
                <td align="center">34,9%</td>
                <td align="center">
								</td>
                <td align="center">0,762</td>
              </tr>
              <tr>
                <td align="left">Estatina</td>
                <td align="center">53,3%</td>
                <td align="center">
								</td>
                <td align="center">82,5%</td>
                <td align="center">
								</td>
                <td align="center">0,035</td>
              </tr>
              <tr>
                <td align="left">Nitrato</td>
                <td align="center">40%</td>
                <td align="center">
								</td>
                <td align="center">36,5%</td>
                <td align="center">
								</td>
                <td align="center">1</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="TFN9">
              <p>IMC: &#237;ndice de massa corporal; PAS: press&#227;o arterial sist&#243;lica; FC: frequ&#234;ncia card&#237;aca; FEVE: fra&#231;&#227;o de eje&#231;&#227;o do ventr&#237;culo esquerdo; AE: medida do &#225;trio esquerdo; DDFVE: di&#226;metro diast&#243;lico final do ventr&#237;culo esquerdo; DSFVE: di&#226;metro sist&#243;lico final do ventr&#237;culo esquerdo; PSAP: press&#227;o sist&#243;lica de art&#233;ria pulmonar; IECA: inibidor da enzima conversora do angiotensinog&#234;nio; BRA: bloqueador do receptor AT-2 da angiotensina. Utilizado Mann-Whitney para vari&#225;veis cont&#237;nuas (expressas em mediana e intervalo interquartil) e teste exato de Fisher para as categ&#243;ricas (expressas em porcentagem).</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>As principais causas da n&#227;o aplicabilidade do <italic>strain</italic> foram a presen&#231;a de infarto pr&#233;vio (56,4%), ATC pr&#233;via (22,1%), revasculariza&#231;&#227;o cir&#250;rgica (RM) pr&#233;via (11,5%), RM e ATC pr&#233;vias (16,7%), e presen&#231;a das seguintes altera&#231;&#245;es eletrocardiogr&#225;ficas: BRE, FA, onda Q patol&#243;gica e ritmo de marcapasso (12,8%).</p>
        <p>No grupo A, a maioria dos pacientes apresentava risco baixo ou intermedi&#225;rio, conforme detalhado na <xref ref-type="table" rid="t10">Tabela 5</xref>.</p>
        <table-wrap id="t10">
          <label>Tabela 5</label>
          <caption>
            <title>Escore de risco dos pacientes submetidos &#224; an&#225;lise do <italic>strain</italic> longitudinal</title>
          </caption>
          <table frame="hsides" rules="groups">
            <colgroup>
              <col width="50%"/>
              <col width="50%"/>
            </colgroup>
            <thead>
              <tr>
                <th align="left">Escore</th>
                <th align="center">Frequ&#234;ncia (%)</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left">
                  <bold>GRACE</bold>
                </td>
                <td align="center">
								</td>
              </tr>
              <tr>
                <td align="left">&#8804; 108 pontos</td>
                <td align="center">86,7%</td>
              </tr>
              <tr>
                <td align="left">109-139 pontos</td>
                <td align="center">13,3%</td>
              </tr>
              <tr>
                <td align="left">&#8805; 140 pontos</td>
                <td align="center">0%</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="TFN10">
              <p>GRACE - Baixo risco - &#8804; 108, moderado risco - 109 a 139, &#8805; 140 - alto risco</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>A avalia&#231;&#227;o da anatomia coron&#225;ria revelou les&#227;o grave em TCE em 1 caso (6,7%). O n&#250;mero de doentes com les&#245;es graves nas art&#233;rias coron&#225;rias DA, CX e CD foi de 2 (13,3%), 4 (26,7%) e 4 (26,7%), respectivamente.</p>
        <p>A avalia&#231;&#227;o do SL2D revelou um valor de <italic>strain</italic> global reduzido naqueles que apresentavam les&#227;o grave em alguma art&#233;ria coron&#225;ria epic&#225;rdica (17,1 [3,1] <italic>versus</italic> 20,2 [6,7] com <italic>p</italic> = 0,014), &#225;rea sob a curva ROC 0,875, conforme demonstrado <xref ref-type="fig" rid="f5">Figuras 2</xref> e <xref ref-type="fig" rid="f6">3</xref>.</p>
        <p>
          <fig id="f5">
            <label>Figura 2</label>
            <caption>
              <title>Curva ROC para avaliar a capacidade do strain global em identificar les&#227;o grave (&gt;70%) em alguma art&#233;ria coron&#225;ria epic&#225;rdica. &#193;rea sob a curva ROC 0,875, com p &lt; 0,014.</title>
            </caption>
            <graphic xlink:href="1678-4170-abc-110-04-0354-80062-gf02-pt.jpg"/></fig>
        </p>
        <p>
          <fig id="f6">
            <label>Figura 3</label>
            <caption>
              <title>Caso de paciente com angina inst&#225;vel, art&#233;ria coron&#225;ria descendente anterior com les&#227;o de 90% no ter&#231;o proximal e art&#233;ria coron&#225;ria circunflexa com les&#227;o de 70% no ter&#231;o m&#233;dio.</title>
            </caption>
            <graphic xlink:href="1678-4170-abc-110-04-0354-80062-gf03-pt.jpg"/></fig>
        </p>
        <p>A avalia&#231;&#227;o do <italic>strain</italic> segmentar demonstrou associa&#231;&#227;o entre les&#227;o grave em CX e redu&#231;&#227;o do <italic>strain</italic> longitudinal do segmento basal da parede lateral (14[5] <italic>versus</italic> 21 [10] com p = 0,04 e &#225;rea sob a curva ROC = 0,864), al&#233;m de associa&#231;&#227;o entre les&#227;o grave em CD e redu&#231;&#227;o do <italic>strain</italic> longitudinal do segmento basal da parede inferior (12,5 [6] <italic>versus</italic> 19 [8] com p = 0,026 e &#225;rea sob a curva ROC = 0,86).</p>
      </sec>
      <sec sec-type="discussion">
        <title>Discuss&#227;o</title>
        <p>A aquisi&#231;&#227;o de imagens pelo ST, com determina&#231;&#227;o do <italic>strain</italic> longitudinal, permite uma avalia&#231;&#227;o mais completa da fun&#231;&#227;o mioc&#225;rdica, podendo detectar altera&#231;&#245;es sutis na contratilidade segmentar de pacientes com cardiopatia isqu&#234;mica, com boa reprodutibilidade inter e intraobservador.<xref ref-type="bibr" rid="B7">7</xref><sup>,</sup><xref ref-type="bibr" rid="B12">12</xref> Dessa forma, o m&#233;todo vem ganhando cada vez mais espa&#231;o na avalia&#231;&#227;o de doen&#231;a arterial coronariana (DAC), com grande n&#250;mero de estudos produzidos nos &#250;ltimos anos.<xref ref-type="bibr" rid="B15">15</xref><sup>-</sup><xref ref-type="bibr" rid="B17">17</xref>
				</p>
        <p>O presente estudo &#233; um dos pioneiros na avalia&#231;&#227;o da aplicabilidade do <italic>strain</italic> longitudinal em pacientes com AI atendidos em Pronto Atendimento de um Hospital Cardiol&#243;gico de n&#237;vel Terci&#225;rio.</p>
        <p>As caracter&#237;sticas cl&#237;nicas, eletrocardiogr&#225;ficas e ecocardiogr&#225;ficas da popula&#231;&#227;o estudada demonstram a complexidade dos pacientes com DAC. Isso provavelmente justifica a baixa aplicabilidade do m&#233;todo, visto que existem muitas vari&#225;veis (existentes na maioria dos pacientes estudados) que poderiam prejudicar a detec&#231;&#227;o de deformidade reduzida por isquemia. Destacamos que na popula&#231;&#227;o estudada 56,1% tinham infarto pr&#233;vio e 44,6% tinham procedimento card&#237;aco pr&#233;vio (ATC, RM ou ambos).</p>
        <p>Shimoni et al.,<xref ref-type="bibr" rid="B18">18</xref> avaliaram o SL2D em 97 pacientes hospitalizados com angina e fun&#231;&#227;o ventricular normal; destes, 69 pacientes apresentaram doen&#231;a coron&#225;ria importante. A an&#225;lise do <italic>strain</italic> global foi de -17,3 &#177; 2,4 com uma &#225;rea sob a curva ROC (AUC) de 0,80 para identificar DAC importante em pacientes com angina; no subgrupo dos pacientes com angina inst&#225;vel o <italic>strain</italic> global tamb&#233;m demonstrou boa acur&#225;cia em predizer DAC obstrutiva angiogr&#225;fica (AUC = 0,86).<xref ref-type="bibr" rid="B18">18</xref> Os achados desse estudo s&#227;o semelhantes aos que encontramos em rela&#231;&#227;o a acur&#225;cia diagn&#243;stica do <italic>strain</italic> para identificar DAC importante na angina, entretanto, n&#227;o houve refer&#234;ncia quanto a aplicabilidade do m&#233;todo na amostra.</p>
        <p>Verificamos no presente estudo uma associa&#231;&#227;o estatisticamente significativa entre valores reduzidos do <italic>strain</italic> global com a presen&#231;a de DAC anatomicamente grave, e acur&#225;cia similar a dados dispon&#237;veis na literatura.<xref ref-type="bibr" rid="B19">19</xref> Quando analisado o <italic>strain</italic> segmentar, encontramos uma associa&#231;&#227;o significativa apenas na redu&#231;&#227;o da deformidade do segmento basal das paredes lateral e inferior, com estenose &#8805; 70% nas coron&#225;rias CX e CD, respectivamente. Acreditamos que os achados do <italic>strain</italic> segmentar seriam mais robustos se a amostra fosse maior.</p>
        <p>Em metan&#225;lise publicada em 2016 com 1385 pacientes inclu&#237;dos em 10 estudos, o <italic>strain</italic> global longitudinal demonstrou boa acur&#225;cia em detectar DAC moderada a importante em pacientes sintom&#225;ticos com AUC de 0,81, sensibilidade de 74,4% e especificidade de 72,1%.<xref ref-type="bibr" rid="B19">19</xref>
				</p>
        <p>Apesar da baixa aplicabilidade do SL2D no PS e UCO, muito provavelmente decorrente do perfil de pacientes que nossa institui&#231;&#227;o atende, as evid&#234;ncias atuais e nossos achados indicam que esse m&#233;todo pode ser exame complementar no algoritmo diagn&#243;stico de DAC e ferramenta &#250;til na avalia&#231;&#227;o precoce da isquemia.</p>
      </sec>
      <sec sec-type="conclusions">
        <title>Conclus&#227;o</title>
        <p>Em 80,8% dos casos, n&#227;o foi poss&#237;vel aplicar o <italic>strain</italic> longitudinal, devido principalmente, aos seguintes crit&#233;rios: presen&#231;a de infarto pr&#233;vio ou revasculariza&#231;&#227;o (percut&#226;nea ou cir&#250;rgica) pr&#233;via. Acreditamos que aplicabilidade do m&#233;todo num perfil de pacientes com menor complexidade cl&#237;nica seria maior, devido &#224;s limita&#231;&#245;es t&#233;cnicas do m&#233;todo.</p>
        <p>A despeito dessa limita&#231;&#227;o, podemos observar que o <italic>strain</italic> global demonstrou correla&#231;&#227;o com presen&#231;a de les&#227;o coron&#225;ria anatomicamente grave. Desta forma, o SL2D poderia ser inclu&#237;do no arsenal diagn&#243;stico de AI, nas unidades de emerg&#234;ncia, visto que &#233; um exame n&#227;o invasivo e com informa&#231;&#227;o diagn&#243;stica disponibilizada em curto espa&#231;o de tempo.</p>
      </sec>
    </body>
    <back>
      <fn-group>
        <fn fn-type="financial-disclosure">
          <p>
            <bold>Fontes de financiamento</bold>
          </p>
          <p>O presente estudo n&#227;o teve fontes de financiamento externas.</p>
        </fn>
        <fn fn-type="other">
          <p>
            <bold>Vincula&#231;&#227;o acad&#234;mica</bold>
          </p>
          <p>N&#227;o h&#225; vincula&#231;&#227;o deste estudo a programas de p&#243;s-gradua&#231;&#227;o.</p>
        </fn>
        <fn fn-type="other">
          <p>
            <bold>Aprova&#231;&#227;o &#233;tica e consentimento informado</bold>
          </p>
          <p>Este artigo n&#227;o cont&#233;m estudos com humanos ou animais realizados por nenhum dos autores.</p>
        </fn>
      </fn-group>
    </back>
  </sub-article>
</article>
